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General Abstract
Eastern oysters, Crassostrea virginica, possess numerous humoral defense factors.
They include lectins, lysosomal enzymes, the prophenoloxidase-activating system, acid
phosphatases, and stress proteins. Recent attention has focused on the role of protease
inhibitors in humoral defense against Dermo, a disease caused by the oyster pathogen,
Perkinsus marinus. Protease inhibitors have been described in numerous vertebrates and
invertebrates. They serve as important regulatory molecules and as potent mechanisms
o f neutralizing pathogen virulence factors. In this study, low molecular weight (LMW)
protease inhibitory activity (PI) was detected in the plasma of eastern oysters. The PI
was determined to be specific for extracellular proteases of P. marinus and was capable
o f preventing the proteolytic digestion of a specific oyster plasma protein of 35 kDa. The
role of LMW PI in disease resistance was then posed. This led to the analysis of LMW
PI in ten selectively bred families of oysters exhibiting varying degrees of
Haplosporidium nelsoni (MSX) and P. marinus-resistance. Results showed a correlation
of PI with survival and with disease intensity. The higher surviving families exhibited
higher PI on average and more heavily infected oysters exhibited lower PI. Additionally,
an F4 generation of MSX-resistant oysters displaying resistance to Dermo was compared
to two stocks of oysters endemic to the Chesapeake Bay in terms of PI, survival, and
average disease intensity. There was no correlation between PI and survival; however, a
weak correlation similar to the selected families was observed between PI and disease
intensity. The question o f PI dynamics during P. marinus infection progression was also
posed. Susceptible oysters were experimentally challenged with live and killed P.
marinus and PI monitored over a five week period. Results indicate that PI was inducible

in both treatments at week 1 post-challenge (p.c.), however, oysters challenged with live
P. marinus continued to show decreases in PI at week 5 p.c. In contrast, PI stabilized in
the treatment challenged with killed P. marinus at week 5 p.c. Results of the four
experiments suggest that LMW protease inhibitors play a role in conferring resistance to
higher infection intensities o f Dermo.
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Chapter 1
Analysis of the Effects of Perkinsus marinus Proteases
on Plasma Proteins of the Eastern (Crassostrea virginica)zn.d.
Pacific Oyster (Crassostrea gigas)

Jacques L. Oliver, Teresa D. Lewis, Mohamed Faisal, and Stephen L. Kaattari1
Department o f Environmental Sciences, School of Marine Science
Virginia Institute of Marine Science, The College of William and Mary
Gloucester Point, Virginia 23062 USA

Abbreviations: PBS phosphate buffered saline, SDS-PAGE sodium dodecyl sulfatepolyacrylamide gel electrophoresis, kDa kilodalton, ppt part per thousand, T-TBS
Tween-tris buffered saline, PVDF polyvinylidene difluoride, ECL enhanced
chemiluminesence, pi isoelectric point, IEF isoelectric focusing, BCA bicinchoninic acid,
DTT dithiothrietol

Manuscript in format for publication in the Journal of Invertebrate Pathology, 74:173183.
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Abstract
We employed two in vitro buffer systems to determine the potential pathogenic
effects of Perkinsus marinus serine proteases on the plasma proteins of the eastern oyster
{Crassostrea virginica) and the Pacific oyster {Crassostrea gigas). Specifically, this
study characterized the oyster plasma protein targets of P. marinus proteases.
Additionally, protease-specific inhibitory activity was revealed upon comparison of
artificial (PBS) and endogenous (plasma-based) diluents employed during protease
digestions. It was found that a C. virginica plasma protein of approximately 35 kDa was
eliminated when a standard buffer (PBS) was used as a diluent; however, this protein was
preserved when a low-molecular weight, plasma-based, diluent was used. The results
strongly indicate that low-molecular weight inhibitors of P. marinus proteases are present
in oyster plasma. A control (non-parasitic) serine protease, a-chymotrypsin, was
employed to ascertain the specificity of the protease inhibitors. Although achymotrypsin possesses ample proteolytic activity for C. virginica plasma proteins, the
anti-proteases could only specifically inhibit P. marinus proteases. Such specificity of
anti-protease activity is not uncommon among low-molecular weight serine proteases.
The hemolymph target protein was isolated by 2D electrophoresis and the isoelectrically
isolated for further characterization by N-terminal amino acid sequencing.
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Introduction
Perkinsus marinus is a protozoan pathogen (Apicomplexa, Levine, 1978) that is the
causative agent of Dermo, a lethal disease afflicting the eastern oyster {Crassostrea
virginica) (Andrews, 1988). Although aspects of the disease process such as adverse
physiological effects on the eastern oyster (Paynter, 1996) and abiotic effects on the
susceptibility, transmission, and infectivity of P. marinus (Chu, 1996) have been
addressed, little is known o f the pathogenic mechanisms employed (Anderson, 1996).
Such knowledge is necessary for designing therapeutic and prophylactic modalities.
Successful in vitro propagation of the pathogen, as described by La Peyre et al.
(1993), has provided the means to isolate and analyze the virulence factors of P. marinus.
Among the in vitro secreted extracellular proteins of P. marinus, La Peyre and Faisal
(1995) discovered chymotrypsin-like serine proteases. They demonstrated that these
proteases were capable of digesting a variety of proteins including hemolymph proteins.
As with many other pathogens (McKerrow, 1989, McKerrow et al., 1993) the possibility
that these proteases could also facilitate invasion, compromise host defense mechanisms,
and provide the invading pathogen with suitable nutrients has been explored. In this
context, it was demonstrated that P. marinus proteases can compromise immune defense
mechanisms of the eastern oyster (Garreis et al., 1996) and favor the protozoan’s
propagation in oysters (La Peyre et al., 1996). Identification and characterization of
putative molecular targets o f P. marinus proteases, however, has yet to be performed.
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One impediment to these studies has been the general dearth of knowledge regarding the
protein composition of oyster plasma.
Of additional importance to P. marinus pathogenesis research is the fact that Pacific
oysters (Crassostrea gigas) contract only light infections upon exposure. Meyers et al.
(1991) found that prevalences and mortalities in diploid and triploid C. gigas exposed to
P. marinus were lower than that in diploid and triploid C. virginica. This suggested a
tolerance of C. gigas to P. marinus, however, the exact mode of resistance o f Pacific
oysters to Dermo remains to be elucidated. Meyers et al. (1991), however, postulated
that the pathogen might be unable to proliferate in C. gigas. In fact, La Peyre (1993)
noted the lower hemolymph protein concentrations in Pacific oysters may pose a
nutritional limitation for the pathogen. Alternatively, C. gigas might possess specific
defense mechanisms that allow the host to eliminate the pathogen.
This study was conducted to determine which plasma components may be the
primary targets o f P. marinus proteases in C. virginica and C. gigas. Such information
may be critical in revealing the possible molecular basis of Perkinsus pathogenesis.
Paramount to such studies is the development of a protease assay system that simulates in
vivo physio-chemical conditions. It was found that when an artificial buffer, PBS, was
employed in the protease assay system a distinctly different digestion pattern o f plasma
proteins is observed than that observed with an endogenous, plasma-based diluent. Based
on these observations, the existence of low-molecular weight protease inhibitors in oyster
plasma was revealed and that these inhibitors were protease specific.
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Materials and Methods
Oysters
Eastern oysters (shell height approximately 70-80 mm) were purchased from
Permaquid Inc., Waldoboro, Maine and acclimated for three months in filtered York
River (Virginia) water. Oysters were notched and approximately 3-4 ml o f hemolymph
were bled from the adductor sinus using a syringe and 25 gauge needle. Hemolymph was
then filtered using a 0.45 pm filter (Costar Scientific Corp., Cambridge, MA) and
aliquots stored in sterile microfuge tubes at -80°C until further use. Oyster plasma was
assayed for protein determination using BCA protein assay kit (Pierce, Rockford, IL).
Pacific oysters, Crassostrea gigas, were obtained from Lookout Point Oyster
Company (Lookout Point, Oregon). Oysters were notched and bled immediately upon
arrival as described above. Hemolymph was sterile filtered using 0.45 pm filter (Costar)
and aliquots stored at -80°C until further use. Protein determinations of plasma were
determined using the BCA assay (Pierce).

Perkinsus marinus Extracellular Protein (ECP) Preparation
Perkinsus marinus -1 cells were cultured for 8 weeks in JL-ODRP-1 medium (La
Peyre et al., 1993). Culture supernatants were obtained by centrifuging the cultures at
3600 x g in 50 ml centrifuge tubes at 4°C for 20 minutes. The supernatants were
decanted into Centriprep-10 concentrators (Amicon Inc., Beverly, MA) and centrifuged

at 3600 x g for 40 minutes at 4°C. After centrifugation, cold (4° C) PBS (137 mM NaCl,
3 mM KC1, 8 mM Na2HPC>4, 2 mM KH2PO4, pH 7.2) was added to the Centriprep-10
apparatus and the centrifugation step repeated. This procedure was performed three
times to equilibrate the ECP in PBS. ECP was then filtered using a 0.22 pm bottle filter
system (Costar) and stored at 4°C until further use. Protein determination of concentrated
ECP was performed using the BCA protein assay (Pierce).

Detection of Protease Activity
A qualitative analysis of concentrated ECP was performed to detect and confirm the
proteolytic activity of P. marinus proteases. The proteolytic activity of ECP was
analyzed using substrate (gelatin) gel electrophoresis as described by La Peyre et al.
(1995).

Production of C. virginica Plasma Protein Antisera
Female New Zealand rabbits (2.27 kg) (Franklin Rabbitry, Wake Forest, NC) were
immunized with 0.45 ml o f 1:1 emulsion of 200 pg C. virginica plasma/ml PBS and
Freund’s complete adjuvant (Sigma Chemical Company, St. Louis, MO). Fifty
microliters of the emulsion were injected intramuscularly into the hind legs and 4, 100 pi
subcutaneous injections along the back were administered. Rabbit serum was procured
from ear vein bleeds at 2 and 4 months post-injection. Aliquots were frozen at -80°C
until used. Antisera were tested for reactivity with eastern and Pacific oyster plasma
through immunoblot analysis. Results showed cross-reactivity of rabbit antisera to all
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observable proteins in both species of oysters and no cross-reactivity with P. marinus
protein.

Incubation of Oyster Plasma With P. marinus Proteases and a-Chymotrypsin
Ten micrograms of concentrated ECP were placed in a sterile microfiige tube at a
volume of 14 pi. Ten micrograms of C. virginica oyster plasma proteins were added to
the same tube in a volume o f 2 pi. The reaction mixture was brought to a final volume of
100 pi using either PBS or a plasma-based diluent. The latter diluent was generated by
centrifuging oyster plasma in a Centricon-10 concentrator (Amicon Inc.). The filtrate
(containing <10 kDa proteins) was retained and used as the plasma-based diluent. The
pH of the PBS reaction mixture and the plasma-based diluent were 7.2 and 7.4,
respectively. The osmolarity of the reaction mixtures was measured using a Westcor
5500 Vapor Pressure Osmometer (Westcor, Inc., Logan, Utah). The osmometer was
calibrated using 100 and 1,000 mmol/kg standards. Ten microliters of each mixture was
loaded into the osmometer and measured. The osmolarity of the PBS reaction mixture
and the plasma-based diluent was 316 mmol/kg and 476 mmol/kg, respectively. The
reaction mixture was capped and covered with aluminum foil and placed in an end-overend rotator for 24 hours at 17°C. In separate tubes negative controls consisting of an
aliquot of ECP and an aliquot o f oyster plasma were similarly placed on the rotator and
incubated for the same duration.
Ten microliters o f C. gigas plasma protein corresponding to 10 pg of protein were
added to the microfiige tube. Ten micrograms of concentrated ECP were placed in a
sterile microfuge tube at a volume of 13.7 pi. The reaction mixture was brought to a final

volume of 100 pi using PBS or the C. gigas-derived plasma-based diluent generated as
previously described. Negative controls were unmixed ECP and C. gigas plasma
incubated in separate microfuge tubes. The pH of the PBS and plasma-based diluent
reaction mixtures were 7.2 and 7.4, respectively. Osmolarity of the two reaction mixtures
was 407 mmol/kg for the PBS diluent and 854 mmol/kg for the plasma-based diluent.
Osmolarity measurements were made as previously described. Incubations o f the
mixture and controls were performed as previously described.
a-Chymotrypsin from bovine stomach (Sigma) was incubated with eastern oyster
plasma proteins using the methods previously described. Briefly, 10 pg of achymotrypsin diluted in PBS were incubated with 10 pg of eastern oyster plasma
proteins. The remaining volume of the reaction mixture was filled with either PBS or the
plasma-based diluent. Analysis o f targets was performed using SDS-PAGE,
immunoblotting, and colloidal gold staining procedures described above

Identification of Protease Targets in Oysters
After the protease incubation, an aliquot from each reaction mixture was
electrophoresed in a reducing 12% SDS-polyacrylamide gel (Harlow and Lane, 1988)
using a mini-PROTEAN II Cell apparatus (Bio-Rad Laboratories, Hercules, CA). All
samples were prepared in reducing (DTT) sample buffer as described by Harlow and
Lane (1988). The volume of the reaction mixture loaded onto the gel was equivalent to
that which would contain 1 pg of oyster plasma protein. Controls (plasma incubated
without ECP and ECP alone) were analyzed in the same manner. Biotinylated broad
range molecular weight markers (Bio-Rad) were loaded as a reference. After
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electrophoresis proteins were transblotted at 100 V for 1 hour to PVDF membranes
(Millipore Corp., Burlington, MA) as described by the Mini Trans-blot Electrophoretic
Cell Manual (Bio-Rad) and immunoblotting analysis was performed to more readily
identify oyster plasma protein targets. Following transblotting, membranes were blocked
with T-TBS (0.1% (v/v) Tween20, 25mM Tris, 137 mM NaCl, 3 mM KC1, 8 mM
Na2 HP0 4 , 2 mM KH2 PO4 , pH 7.2) (Arkoosh and Kaattari, 1990) overnight at 4°C.
Membranes were incubated on a shaker at room temperature with a rabbit antiserum
generated against C. virginica plasma proteins (diluted 1:5,000 in T-TBS) for 1.5 hours.
Membranes were washed 3 times in T-TBS at 5 minutes per wash. Membranes were
incubated with a goat-anti-rabbit-HRPO antibody (Sigma Chemical Company) (diluted
1:5,000 in T-TBS) and streptavidin-horse radish peroxidase (diluted 1:1,000 in T-TBS)
for molecular weight marker identification for 1 hour at room temperature. Membranes
were washed five times in T-TBS. ECL reagents (Amersham Life Science,
Buckinghamshire, England) were used for chemiluminescent development o f the
membranes on ECL Hyperfilm (Amersham Life Science). Following ECL development,
membranes were rinsed 10 times with deionized-distilled water and total protein stained
with Colloidal Gold Stain (Bio-Rad). Target protein molecular weight determination was
performed via comparison to molecular weight standards using densitometric analysis
(Integrated Separation Systems Enprotech, Natick, MA).
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Two-Dimensional Isoelectric Focusing and Western Blot of Eastern Oyster Plasma
Proteins
A two-dimensional IEF analysis was performed to determine potential pi diversity of
the 35 kDa target in the eastern oyster plasma previously identified in the above analyses.
First dimension IEF tube gels were prepared and samples electrophoresed according to
the methods described by Harlow and Lane (1988) using the Bio-Rad Minigel apparatus.
Each tube gel was layered upon 12% SDS-polyacrylamide gels for second dimension
electrophoresis. In order to attain reducing conditions for the tube gel, 200 pi of reducing
(DTT) sample buffer prepared according to Harlow and Lane (1988) was added on top of
the tube gel. After second dimension electrophoresis was performed, proteins were
transblotted to PVDF membranes, immunoblotted, and stained by the methods previously
described.

N-Terminal Amino Acid Sequencing and Amino Acid Composition o f Eastern Oyster
Target Proteins
Five micrograms of target protein were isolated via 2D IEF as previously described.
Preparation of the membrane for N-terminal sequencing and amino acid analysis was
performed using a protocol (Gilardi, M. L., 1996) provided by Commonwealth
Biotechnologies, Inc. (Richmond, VA). Briefly, following transblot of proteins to a
PVDF membrane, the membrane was stained with 0.1% (v/v) Coomassie Brilliant Blue
R-250 in 50% (v/v) methanol/deionized-distilled water for 5 minutes at room
temperature. Membranes were destained with 50% methanol, 10% acetic acid, 40%
deionized-distilled water for 10 minutes at room temperature. Membranes were rinsed
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twice with deionized-distilled water, equilibrated for 10 minutes in deionized-distilled
water, and then air dried for 1 hour. The target protein band was excised from the
membrane and sent to Commonwealth Biotechnologies, Inc. for N-terminal amino acid
sequencing and amino acid composition analysis. Sequence information was compared
to known sequences by searching SWISSPROT using BLASTP (2.0.8). The Expect
value (E) in the database search was increased to 1,000 to provide statistically significant
or non-significant matches.

Results
Oyster Plasma Protein Digests Using PBS and Plasma-Based Diluents PBS diluent
Co-incubation of C. virginica plasma proteins with P. marinus proteases using a PBS
diluent resulted in the complete elimination of a 35 kDa protein band (Figures la & lb,
lane 3 - arrow). An immunoblot using a rabbit anti-C. virginica plasma permitted a
clearer resolution o f the digested oyster “target” protein (Figure la, lane 4 - arrow). It
should be noted that an additional band appears upon digestion (Figure la, lane 3 asterisk). It is unlikely that this band represents cross-reactivity with P. marinus ECP
since no such band is apparent in lane 2. The appearance of this band suggests that it
may be a product of partial proteolytic digestion of an, as yet to be determined, high
molecular weight species by ECP.
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Plasma-based diluent
Use of a physiologically relevant plasma-based diluent revealed a strikingly different
digestion profile from that observed with PBS. Under these conditions the 35 kDa
protein band remains substantively intact (Figures lc & Id, lane 3 -arrow). Although the
35 kDa protein appears protected in this diluent, some partial digestion appears to be
occurring, as new, low molecular weight species are generated (Figures lc & Id, lane 3 asterisks).
Plasma proteins from the relatively P. marinus-resistant oyster, C. gigas, were
exposed to P. marinus proteases under identical conditions used with C. virginica (Figure
2). In this case, the PBS diluent did not support the complete digestion of any plasma
proteins, however, partial digestion appears to be occurring with a protein of
approximately 66 kDa (Figures 2a & 2b, lane 3 - circle). In addition, some breakdown
products of approximately 35 kDa are observed (Figures 2a & 2b, lane 3 - brackets)
which may be due to degradation of high molecular weight proteins. In the presence of
the plasma diluent a more intense digestion of the higher molecular weight species
(approximately 66 kDa) (Figures 2c & 2d, lane 3 - circle) occurs, leaving an assortment
of lower molecular weight species (Figures 2c & 2d, lane 3 - bracket). However,
digestion is not as thorough as with C. virginica proteins.

Effects of a-Chymotrypsin on Eastern Oyster Plasma Protein Substrates
Incubation of eastern oyster plasma with a non-Perkinsus (bovine) serine protease,
a-chymotrypsin, in PBS resulted in proteolysis of the 35 kDa target as was demonstrated
with P. marinus serine proteases (Figures 3a & 3b, lane 3 - arrow). In addition to the
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elimination of the 35 kDa target, a 30 kDa band becomes apparent (Figures 3a & 3b, lane
3 - asterisk). It is likely that the 30 kDa band represents degradation products o f the 35
kDa target protein.
When the diluent was switched from PBS to the plasma-based diluent, the result was
unchanged. Eastern oyster plasma proteins were digested (Figures 3c & 3d, lane 3 arrow). In addition, there appear to be degradation products at 30 kDa (Figure 3c, lane 3
- asterisk) as seen in Figures 3a and 3b, lane 3.

Two-Dimensional Isoelectric Focusing of Eastern Oyster Plasma Proteins
Further characterization o f the plasma proteins by two-dimensional isoelectric
focusing (2D IEF) and immunoblotting revealed a rather restricted pi heterogeneity for
the 35 kDa target protein (Figure 4a). Specifically, the 35 kDa target of the eastern oyster
shows no pi heterogeneity and the target is composed of a single protein (Figures 4a & 4b
- circle/arrow). Identification o f the target can be determined upon comparison o f the 2D
IEF of oyster plasma exposed to ECP (Figures 4c & 4d - circle/arrow) and the oyster
plasma control (Figure 4c, lane 2 -arrow). Comparison of figures 4a and 4c reveals
elimination of a second target near 66 kDa not previously seen in one-dimensional
immunoblotting (Figures 4a & 4c - circle/asterisk). The isoelectric point range for the 35
kDa target is 5.9 - 6.6.
A second 2D IEF o f oyster plasma proteins was performed. Proteins were
transblotted and non-covalently stained. N-terminal amino acid sequencing and amino
acid composition analysis revealed the first 10 amino acid residues (Table 1). Amino
acid composition analysis revealed the target to be abundant in serine, glycine, and

alanine (Table 2). Database searches were performed to match the obtained sequence
with other known amino acid sequences. Results revealed best match to be with plant
plasma membrane ATPases (50% identity), however these matches were considered to be
statistically non-significant due to the high Expect values (E) of the returned matches
(data not shown).

Discussion
This study was conducted to analyze the in vitro pathogenic effects o f P. marinus
proteases on plasma proteins o f two oysters, C. virginica and C. gigas. When C.
virginica proteins were incubated with P. marinus ECP, degradation of a 35 kDa protein
was observed. One-dimensional SDS-PAGE of host plasma proteins allowed us to
characterize the molecular weight of the target, however, two-dimensional isoelectric
focusing and electrophoresis was required to determine the possible isoelectric
heterogeneity of proteins. The isoelectric diversity of the target appears to be limited and
consisting of one or possibly two proteins.
Our experiments were designed to determine any plasma protein targets of P.
marinus proteases, however, we were able to additionally identify a potentially novel host
defense factor in C. virginica plasma. Initial in vitro experiments with host plasma
proteins and P. marinus ECP in PBS (pH 7.2) showed consistent digestion o f host
proteins. Later experiments employed a plasma-based diluent derived by removing large
(>10 kDa) molecular constituents of the plasma. This fraction was used in place o f PBS
as the reaction mixture diluent to determine if an endogenous diluent would reveal
comparable effects as PBS. Under these conditions preservation of the host target protein
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occurred. The most likely reason for this lack of activity in the plasma-based diluent
would be the supplementation of protease inhibitors. Analysis of the <10 kDa plasma
diluent with 8 kDa pore size membrane resulted in retention of the inhibitory activity
(data not shown). This indicates that the inhibitory activity resides with 8-10 kDa sized
molecule(s) and cannot be due to factors such as minor differences in pH, osmolarity, or
other aspects of ion or low molecular weight composition. Furthermore, evidence that
osmolarity of each diluent (PBS, C. virginica-derived or C. g/gas-derived) was not a
factor affecting proteolytic activity is the observation that expression and activity of P.
marinus proteases occurs in a culture medium with elevated osmolarity (650 mmol/kg)
(La Peyre et al., 1993; La Peyre et al., 1995). Further evidence that pH was not a factor
affecting proteolytic activity is the finding that P. marinus protease activity occurs in a
variety of buffers with varying pH (5.0-9.5), including PBS (La Peyre et al., 1995). Thus,
if plasma protease inhibitors are operative, it may be that dilution of plasma in PBS may
effectively reduce endogenous inhibitors to a concentration insufficient to block the
activity of P. marinus proteases. Protease inhibitors are known to be important
regulatory molecules as well as having importance in humoral defense (Ellis, A., 1987;
Calkins and Sloane, 1995; Wiedow et al., 1998). Furthermore, protease inhibitors have
been identified in a number o f marine invertebrates (Donovan and Laue, 1991; Sousa, M.
et al., 1992) and specifically in molluscs (Bender et al., 1992; Thorgersen et al., 1992;
Armstrong and Quigley, 1992).
La Peyre et al. (1995) noted the similarity of P. marinus proteases to chymotrypsinlike enzymes. Incubations o f eastern oyster plasma with another serine protease, achymotrypsin, were undertaken to compare specificity P. marinus proteases and a-
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chymotrypsin for plasma proteins. Additionally, the specificity of the inhibitory activity
in the <10 kDa fraction o f eastern oyster plasma against a-chymotrypsin was examined.
Results showed that a-chymotrypsin can recognize and proteolytically digest eastern
oyster plasma proteins. Thus, P. marinus serine proteases and a-chymotrypsin share
substrate specificity. However, whereas P. marinus proteases were successfully inhibited
from digesting oyster proteins with the endogenous inhibitor, a-chymotrypsin was
uninhibited. This differential sensitivity among serine proteases is common. For
example, La Peyre et al. (1995) showed that P. marinus proteases exhibited low activity
in the presence of PMSF and chymostatin, but were quite active in the presence o f other
serine protease inhibitors such as 3,4-DCI and elastatinal. Additionally, Faisal et al.
(1998) suggested that the ability o f C. gigas to strongly inhibit P. marinus proteases yet
weakly inhibit trypsin was due to specificity of protease inhibitors in Crassostrea spp.
Thus, it appears that inhibitory activity of the eastern oyster is specific and may have
developed and been directed against P. marinus proteases.
Pacific oysters have been o f particular interest due to their ability to resist the P.
marinus upon challenge (Meyers, 1991). Having observed the patterns of susceptibility
and resistance of eastern oyster plasma proteins to P. marinus proteases, it was of interest
to determine the effects on Pacific oyster plasma proteins. Results demonstrated that C.
gigas plasma proteins are susceptible to proteolysis in both diluents. Despite the apparent
partial digestion of an approximately 66 kDa protein in Pacific oyster plasma, the
sensitivity of this protein appears to be less than the sensitivity of the p35 target in the
eastern oyster, as p35 was completely eliminated under identical conditions. Although
there appears to be a target o f P. marinus proteases within Pacific oyster plasma, there
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are a number of possibilities that may preclude disease susceptibility being contingent
upon the loss of this target. The

6 6

kDa target may be inconsequential to any vital

process in the Pacific oyster. Alternatively, the incomplete proteolysis of the protein
suggests that the protein is only slightly sensitive to P. marinus proteases and full
elimination of this protein does not occur. Finally, there may be mechanisms utilized by
Pacific oysters outside the scope o f this in vitro experiment that prevent P. marinus from
exerting its virulence via proteases. This may occur by suppression of protease
expression or perhaps rapid clearance of the pathogen before replication can occur.
The possible function of the target molecule (p35) within C. virginica hemolymph
may be most readily ascertained by identification of structurally homologous molecules.
Therefore, as the p35 protein was isoelectrically restricted, its isolation and analysis was
readily accomplished. Amino acid composition analysis revealed p35 to be abundant in
serine, glycine, and alanine. Furthermore, the N-terminal amino acid sequence o f the
first 10 residues of p35 was obtained. The closest sequence identity (50%) was found
with plant plasma membrane ATPases when a search was conducted to ascertain
homologous sequences, thus the information gained from the database searches has
provided limited insight into the possible function of the p35 target. Although sequence
matches were identified, it is likely that such matches were merely random occurrences.
This is evident by the high E values (428, 561, and 735) of each match, which signified
low statistical significance.
Additional information, albeit limited, can be gleaned from the amino acid
composition of p35. The abundance of alanine, an uncharged amino acid with a nonaromatic side chain, in p35 is evidence that supports p35 as a specific target of P.
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marinus serine proteases. Kraut (1977) described elastase, another common serine
protease, as having preference for alanine residues. Elastase was 4000 times more
efficient in hydrolyzing peptide substrates with amino acid sequences that contained
consecutive alanine residues. Further inferences about the function and identity o f p35
through amino acid composition cannot be made.
Despite the limited effectiveness of the amino acid analyses for protein
identification, the unique combination of molecular weight and pi are suggestive that p35
might be a subunit o f a serum lectin. Vasta et al. (1984) affinity purified a serum lectin
of C. virginica using rat red blood cells (rRBC) and analyzed it via reducing SDS-PAGE.
Their results showed three subunit bands, OSLS-I (67 kDa), OSLS-II (34 kDa), and
OSLS-III (25 kDa). It is interesting to note the presence of a 34 kDa (OSLS-II) protein
identified by Vasta et al. And our findings of a 35 kDa target in oyster hemolymph.
Additionally, Vasta et al. (1984) isoelectrically focused the serum lectin and found that
the lectin had a broad pi range (pH 5-6 and pH 7-8) with slightly greater heterogeneity
than our 35 kDa target. The affinity purified lectin was also tested for its ability to
agglutinate protease-treated rat, horse, and human O RBC. Immediate comparisons can
be made between the two molecules. They both have a similar molecular weight and
have close pi ranges. However, caution should be taken before any conclusions can be
drawn between the two molecules. It is possible that OSLS-II and p35 merely share
physical characteristics, but functionally they are distinct. Additionally, Vasta et al.
(1984) did not verify other proteins in the hemolymph which were not affinity purified
and may also share a similar molecular weight. To confirm OSLS-II and p35 as the same
molecule, an N-terminal sequence of OSLS-II would have to be determined and
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compared with that o f p35. Further evidence to support homology would be to expose
the serum lectin to P. marinus ECP. Digestion of OSLS-II would support N-terminus
results that OSLS-II and p35 are the same protein and would establish that the serum
lectin is a target of P. marinus proteases.
Confirmation of OSLS-II/p35 homology would have important implications in terms
o f the molecular pathogenesis o f P. marinus. It is widely known that lectins play an
important role in invertebrate humoral and cellular defense (Arason, G. J., 1996).
Elimination o f an oyster defense molecule used in non-self recognition by pathogen
proteases would represent a pathogenic mechanism not previously described in the
eastern oyster.
There is a general dearth of knowledge concerning protease inhibitors in the
hemolymph of oysters. Previous studies on the serological and hemolymph composition
of eastern oysters have focused on lysozyme activity, agglutinins, and hemocyte
characterization and responses (Cheng and Rodrick, 1975; Chu and La Peyre, 1989; Li
and Flemming, 1967; Chintala et al., 1994; Anderson et al., 1995; Anderson, 1996).
However, in a recent study Faisal et al. (1998) provided evidence that C. virginica and C.
gigas were capable o f producing protease inhibitors. These findings support our
observations that protease inhibitors are present in C. virginica although we could not
infer the presence of protease inhibitors in C. gigas. Our study does not preclude the
possibility that C. gigas can produce protease inhibitors, particularly high molecular
weight inhibitors. In fact, Faisal et al. (1998) observed much higher protease inhibitory
activity in C. gigas towards P. marinus proteases than C. virginica and speculated that
this inhibitory activity could be attributed to high molecular weight species such as ot2 -
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macro globulin-like molecules. In addition, previous studies by Adham and Faisal (1997)
suggested the presence o f a 2 -macroglobulin-like activity in C. virginica and C. gigas
plasmas. This difference in protease inhibitory activity between the two species may be
important in the higher susceptibility of C. virginica over C. gigas.
Our findings implicate P. marinus proteases and p35 in the molecular pathogenesis
of the disease. It is possible that the p35 target is vitally important to the survival of the
oyster and its elimination may be important during infection. Although p35 is not
digested by P. marinus proteases when in the presence of plasma-based diluent, it is
possible that p35 can become susceptible during the progression of the disease. This
might occur if the pathogen is capable of compromising host anti-proteolytic activity
observed herein. The work presented here, however, is reflective of in vitro conditions
only. In vitro experiments have solely allowed us to identify and partially characterize
the target. Our data suggest a dynamic interplay between proteases, target proteins, and
inhibitors. A fuller understanding of these potential pathogenic proteases requires in vivo
correlation o f target protein loss with P. marinus infections.
The experiments performed here are important first steps in understanding the role of
P. marinus proteases in the pathogenesis of Dermo. It seems unlikely that P. marinus
proteases are the exclusive virulence factor in Dermo, however, they may very well play
a critical role in disease initiation or progression. The existence of protease inhibitors
within eastern oysters suggests a previously undescribed defense mechanism.
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Table 1 . N-terminal amino acid sequence of the p35 target from the eastern oyster.

H2N - Tyr —Pro - Leu - Glu- His - Asn - Asn -Tyr - Gin - Asp

Table 2. Amino acid analysis of 35 kDa plasma protein target (p35) from C. virginica.
Results indicate abundance of glycine, alanine, serine, and valine in p35.

As(x)
GI(x)
Ser
His
Gly
Thr
Ala
Arg
Tyr
Cystine
Val
Met
Trp
Phe
lie
Leu
Lys
Pro
HyPro
EACA
B-Ala
Cys

nmol
d etected
0.0231
0.018
0.0397
0.0059
0.1307
0.0113
0.0881
0.015
0.0156
0
0.0367
0.003
0
0.0107
0.0066
0.0103
0.0025
0.0228
0
0
0
0

to t nmol
in sam p le
1.848
1.44
3.176
0.472
10.456
0.904
7.048
1.2
1.248
0
2.936
0.24
0
0.856
0.528
0.824
0.2
1.824
0
0
0
0

MGS IN SAMPLE:

equiv
ug
0.21252
0.18576
0.276312
0.064664
0.595992
0.0913040.500408
0.1884
0.203424
0
0.290664
0.03144
0
0.125832
0.059664
0.093112
0.0256
0.176928
0
0
0
0

0.003122

Res/m ol
20.71733
16.14337
35.60511
5.291439
117.2188
10.13445
79.01285
13.45281
13.99092

0
32.91455
2.690562

0
9.596339
5.919237
9.237597
2.242135
20.44827

0
0
0
0
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Figure Legends
Figure 1. Comparison of diluents on P. marinus protease digestions. The products of P.
marinus protease digestions o f C. virginica plasma proteins in the presence of PBS (a, b)
and plasma- based diluents (c, d) were analyzed by 12% reducing SDS-PAGE. Each gel
was immunoblotted (a, c) and colloidal gold stained (b, d) to reveal the total protein.
Lane 1 , biotinylated molecular weight markers; lane 2 , 1.0 pg ECP only; lane 3, 1.0 pg
ECP and 1.0 pg C. virginica proteins; lane 4, 1.0 pg C. virginica proteins only. The
arrows in la, lb, lc, and Id indicate the 35 kDa plasma protein target in C. virginica.
Asterisks in la, lc, and Id denote possible degradation products of P. marinus ECP
digestion.

Figure 2. Comparison o f diluents on P. marinus protease digestions. The products of P.
marinus protease digestions o f C. gigas plasma proteins in the presence of PBS (a, b) and
plasma-based diluent (c, d) were analyzed by 12% reducing SDS-PAGE. Each gel was
immunoblotted (a, c) and colloidal gold stained (b, d) to reveal total protein. Lane 1,
biotinylated molecular weight markers; lane 2, 1.0 pg ECP only; lane 3, 1.0 pg ECP and
1.0 pg C. gigas proteins; lane 4, 1.0 pg C. gigas proteins only. The circles in 2a, 2b, 2c,
and 2d denote partial digestion of C. gigas plasma proteins by P. marinus ECP. Brackets
in 2a, 2b, 2c, and 2 d denote possible degradation products of C. gigas plasma proteins by
P. marinus ECP.
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Figure 3. Comparison o f diluents on a-chymotrypsin digestion of C. virginica plasma
proteins. The products of a-chymotrypsin digestions of C. virginica plasma proteins in
the presence of PBS (a, b) and plasma-based diluent (c, d) were analyzed by 12%
reducing SDS-PAGE. Each gel was immunoblotted (a, c) to reveal the plasma proteins
and colloidal gold stained (b, d) to reveal the total protein. Lane 1, biotinylated
molecular weight markers; lane 2, 1.0 pg a-chymotrypsin only; lane 3 1.0 pg achymotrypsin and 1.0 pg C. virginica plasma proteins; lane 4, 1.0 pg C. virginica plasma
proteins only. The arrows in 3a, 3b, 3c, and 3d indicate the 35 kDa plasma protein target
in C. virginica. Asterisks in 3a, 3b, and 3c denote possible degradation products of achymotrypsin digestion.

Figure 4. Two-dimensional electrophoretic analysis of C. virginica plasma proteins.
Undigested (a, b) and P. marinus protease-digested (c, d) C. virginica plasma protein
samples were analyzed by two-dimensional electrophoretic analysis (isoelectric focusing
- first dimension, 12% reducing SDS-PAGE, second dimension). Each gel was
immunoblotted (a, c) and colloidal gold stained (b, d) to reveal the total protein. Lane 1,
biotinylated molecular weight markers; 2D gel, 1.0 pg C. virginica plasma proteins; lane
2, 1.0 pg C. virginica plasma proteins. The circle with an arrow in 4a, 4b, 4c, and 4d
denotes the 35 kDa plasma protein target in C. virginica. The circle with an asterisk in 4a
and 4c denotes a possible additional plasma protein target.
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Abstract
Selected stocks of eastern oysters, Crassostrea virginica, were interbred to produce
ten families with high inter- and intra-family genetic variability. In an effort to identify
potential biochemical markers for resistance to Dermo, a disease afflicting eastern
oysters, subsamples of two year old oysters from each of these families were assessed for
protease inhibitory activity (PI) against proteases of Perkinsus marinus, the causative
agent of Dermo disease. Prevalence and intensity of the pathogen were assessed via
Ray’s Fluid Thioglycollate Medium (RFTM) test. Family survival under field challenge,
disease intensity, and protease inhibitory activity were compared to evaluate family
performance. In the laboratory, three families had the highest survival, lowest average
number of parasite cells, and highest average PI. In field challenges, the same three
families exhibited the lowest cumulative mortality. Among all families, disease intensity
was negatively correlated with protease inhibitory activity. Mortality patterns also
indicated an inverse relationship between disease intensity and protease inhibitory
activity.
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Introduction
Perkinsus marinus is a protozoan pathogen of the eastern oyster, Crassostrea
virginica, and is the causative agent of the disease known as Dermo (Andrews, 1988).
This pathogen has had a severe economic impact on the commercial oyster fishery in the
Chesapeake Bay. Commercial landings have fallen from 3 million bushels per year in
1960 to less than 100,000 bushels per year in 1994 (Burreson and Ragone Calvo, 1996).
One approach taken toward the rebuilding of oyster populations in endemic disease
environments has been the selective breeding of disease resistant oysters (Haskin and
Ford, 1979; Ewart et al., 1988; Matthiessen et al., 1990; Matthiessen and Davis, 1991;
Burreson, 1991). Groups o f oysters that have exhibited low mortality under heavy
disease conditions have been selected for interbreeding to produce potentially disease
resistant lines. This type of selective breeding has had considerable success with respect
to MSX (Haplosporidium nelsoni) over the past two decades (Gaffney and Bushek,
1996); however, the success in generating Dermo-resistant oysters has been limited
(Gaffney and Bushek, 1996).
Selecting oysters for disease resistance is not a complex process and, at present, it is
thus far the most realistic approach for producing stocks with low mortality from MSX
and Dermo. Individual oysters that survive and grow well in the face of natural field
challenges are selected as spawners for the next generation; their progeny are likewise
field-tested to provide parents for the subsequent generation, and this process is
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continued (Gaffney and Bushek, 1996). Despite its technical ease, this approach
possesses several drawbacks. For example, inter-annual variation in uncontrollable
abiotic factors, such as temperature and salinity, can dramatically affect disease intensity
(Gaffney and Bushek, 1996). Therefore, such factors can easily confound one’s ability to
distinguish between high survival due to resistance and high survival due to low disease
intensity. The slow growth o f oysters and the chronic nature of Dermo can also make
survival a fairly cumbersome selection parameter. It may take several years to determine
whether a developing stock is resistant to the disease (Gaffney and Bushek, 1996).
Alternatively, physiological or biochemical disease resistance markers that can be
examined early in oyster development are more attractive alternatives. Furthermore,
identifying such markers for disease resistance will contribute to understanding the
biochemical aspects of P. marinus molecular pathogenesis. However, presently, there are
no known genetic or biochemical markers for Dermo disease resistance in the eastern
oyster.
One class of potential disease resistance markers could be those molecules involved
in neutralizing the virulence factors of P. marinus. In this vein, La Peyre and Faisal
(1995) originally hypothesized that extracellular proteins (ECP) and serine proteases
secreted by P. marinus might be important virulence factors. Evidence to support this
hypothesis has been garnered over recent years (La Peyre et al., 1996; Garreis et al.,
1996; Faisal et al., 1998). Previous work in our laboratory demonstrated that eastern
oysters possess low molecular weight inhibitory activity directed against these P. marinus
proteases. Specifically, low molecular weight plasma molecules ( 8 - 1 0 kDa) were
observed to inhibit these serine proteases from digesting a specific host plasma protein in
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vitro. Based on this observation, we hypothesized that the observed anti-proteolytic
activity in eastern oysters might be an important host defense factor. Thus, studies have
been initiated to determine if these anti-proteases can serve as biochemical markers for
Dermo resistance.
To test whether there is a relationship between protease inhibitory activity and
disease resistance, ten C. virginica families possessing different genetic backgrounds
were examined. We hypothesized that the genetic variability would facilitate the
identification of phenotypically distinct groups in terms of their ability to resist infections
with P. marinus. Furthermore, we hypothesized that such a phenotypic distinction would
be correlated with protease inhibitory activity.

Materials and Methods
Oysters
Oyster stocks o f specific parentage were bred at the Haskin Shellfish Research
Laboratory (HSRL) (Rutgers University, Cape Shore, NJ) in 1996. The male and female
parent for each family is listed in Table 1. Oysters from each group were individually
examined and sexed microscopically. Crosses were l x l (male from one group crossed
with a female from another group). Females were stripped and eggs cleaned by
consecutive filtration over a 60 pm and 15 pm screen. Following filtration, eggs were
transferred to 100 ml of seawater and counted in duplicate. Eggs were checked for the
presence of sperm that would indicate hermaphroditism. Samples indicating
hermaphrodism were discarded and a new female was used. Males were stripped and
sperm activity was qualitatively assessed. The amount of sperm used for fertilization was
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determined by the activity and density of the sperm from each male. Eggs were fertilized
in a small plastic container (500 ml) by adding sperm at a ratio of 5:1, sperm to egg. The
fertilization rate was estimated one hour post-fertilization by the following equation:
(number of fertilized eggs/total number of observed eggs) X 100. Each family was then
labeled with the appropriate designation (see Table 1). Following fertilization, larvae
were reared in aerated 21 1 -liter tanks at a temperature of 25-27°C and 17-26 ppt salinity.
The food mixture consisted of Isochrysis galbana and Chaetoceros calcitrans at a density
of 60,000 - 100,000 cells/ml. Water changes were made every other day by siphoning
out water with a hose and filtering larvae onto mesh screens. Competent larvae were set
cultchlessly using a 10-4 M epinephrine solution according to the methods adapted from
Coon et al. (1986). Set larvae were transferred to 211 liter downwelling tanks for 10-14
days or until spat reached a shell length of approximately 1 .0 mm. Spat were transferred
to upwelling raceways and maintained until shell length reached 10.0 mm. Juvenile
oysters were transferred to 1 / 8 -inch mesh bags, then rotated to intertidal grow out racks
in Delaware Bay. Oysters were maintained at Cape Shore, NJ for two years until the
initiation of disease challenges. All oysters were exposed to ambient Delaware Bay
water during their maintenance at HSRL.
In June 1998, oysters were transferred to the Virginia Institute of Marine Science and
divided into a laboratory group and a field group. The laboratory group comprised
subsamples of 50 oysters from each family. Laboratory oysters were acclimated in
filtered York River water (25° C, 18 ppt) in a 156-gallon tank for one week. All families
were sampled for Dermo and MSX diagnosis and were subsequently maintained in York
River water filtered through two 1 pm polypropylene filters (Filter Equipment Co., Inc.,
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Wall, NJ). Oysters were held in ambient filtered York River water for the duration o f the
experiment. Oysters were fed 0.3 g algae paste/oyster per day (Thalassosira weissflogii)
and water was changed every other day. The remaining oysters constituted the field
group and were placed in sites in the Chesapeake Bay thought to be endemic only for
Dermo to allow for natural challenges to P. marinus. Oysters were sampled in October
and December 1998, and March 1999 for determination of growth (shell height) and
survival.

Hemolymph
In June 1998, twenty oysters were taken from each family and notched using a
circular saw to expose a small opening into the mantle cavity. Oysters were returned to
the tanks and held for another 3 days to recuperate from notching. Oysters were bled
from the adductor muscle using a 5 cc syringe and 25 gauge needle. Hemolymph was
centrifuged at 400 x g for 10 minutes at 4°C. The cell-free supernatant was filtered
through a 0.22 pm syringe-top filter (Costar Scientific Corp., Cambridge, MA). The
resulting plasma was centrifuged in a Centricon-10 apparatus (Amicon Inc., Beverly,
MA) to fractionate low molecular weight plasma (<10 kDa). The filtrate containing less
than 10 kDa molecules was stored at -20°C until further use. Eight weeks later the
procedure was repeated with the remaining oysters from each family.

Disease Diagnosis
After obtaining hemolymph from oysters from each family, oysters were assayed for
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P. marinus and H. nelsoni infections. Oysters were shucked and gill, mantle, and rectal
tissues were sampled for presence of P. marinus. Diagnosis was performed using Ray’s
Fluid Thioglycollate Method (RFTM) (Ray, 1952,1966) and infections were scored
according to the method described by Mackin (1962). For MSX diagnosis, two oysters
from each family were shucked and oyster tissues were prepared for histological
examination using the methods described by Stokes et al. (1995).

Protease Inhibitory Activity
Protease inhibitory activity within oysters was detected and quantified using the Hide
Powder Azure as a substrate as detailed by Bender et al. (1992). The protocol was
modified for microtiter plate assays. First, P. marinus extracellular proteins (ECP)
containing serine proteases were derived from culture supernatants as described by La
Peyre et al. (1995). A standard curve of P. marinus ECP was generated by assessing
undiluted P. marinus protease and two-fold dilutions (i.e., 1:4, 1:8, 1:16, 1:32, 1:64, and
1:128) in a 96 well microtiter plate (Costar). All dilutions employed in the standard
curve were made using cold (4°C) artificial seawater (Forty Fathoms Marine Mix
Artificial Sea Water, 22 g/L) and were kept on ice. Four microliters of each dilution from
the standard curve was added to wells in triplicate followed by 50 pi of room temperature
(RT) artificial sea water. Fifty-four microliters of artificial seawater at RT was added as
a blank. Four microliters of undiluted protease was added to separate wells in triplicate
followed by 50 pi of low molecular weight (LMW) oyster plasma containing PI activity.
Negative controls consisted of 54 pi of plasma only. A protease control consisted of 4 pi
undiluted protease plus 50 pi RT artificial seawater. The blank for the protease control
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consisted of 54 pi o f RT artificial seawater only. Mixtures of protease and plasma were
incubated at RT for 15 minutes on a shaker. Following incubation, 100 pi of substrate
suspension (Hide Powder Azure, 0.02 g/ml, 150 mM Tris, 30 mM CaCL, 0.05% Brij,
20% sucrose, pH 7.5) was added to each well. Plates were incubated at 37°C on a shaker
for 3 hours. After incubation, 100 pi of cold artificial seawater was added to each well to
stop the reaction. Plates were centrifuged at 2700 x g for 15 minutes at 4°C. One
hundred microliters of supernatant were removed from each well and transferred to
another 96 well microtiter plate. Plates were read at 540 nm on a Titertek® Multiskan®
MCC/340 plate reader (Labsystems, Finland) using DeltaSoft 3 software (BioMetallics,
Inc., Princeton, NJ). Based on the protease standard curve, reduction in A 5 4 0 due to the
inhibition by LMW C. virginica plasma was calculated and expressed as ng P. marinus
protease inhibited/50 pi LMW plasma.

Statistical Analysis
For oysters held in the laboratory, a one-way analysis of variance (ANOVA) was
performed among all families with respect to Mackin Scale and PI. The statistical
analyses were performed using Minitab (version 12.1, Minitab, Inc., State College, PA).
The RFTM scoring for individual oysters from June and August 1998, among all
families, were plotted on the Mackin Scale (negative, rare, light, light to moderate,
moderate, and heavy) and compared by one-way ANOVA (Minitab) with respect to PI.
Oysters that were scored with moderate to heavy infections (n=4) were combined with
oysters that were scored with heavy infections. A Tukey’s multiple comparisons test was
performed according to the methods described by Zar (1996) to detect differences in PI
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between ratings on the Mackin scale. Sigma Plot (version 4.01, SPSS, Inc., San Rafael,
CA) was used to perform a simple linear regression to correlate Mackin scale with PI.

Results
MSX and Dermo Diagnosis
Overall, there was a 21% prevalence of H. nelsoni and an 87% prevalence of P.
marinus at the start of the experiment among all families (data not shown). The degree of
intra-family H. nelsoni prevalence was not determined. However, there was a wide range
of P. marinus prevalence between families. Seven families exhibited greater than 94%
prevalence while the remaining three families exhibited 40%, 70%, and 80% prevalence,
respectively (Table 2). Furthermore, the intensity of P. marinus infections among
families varied from rare to moderate infections.

Inter-family Disease Intensity, PI, and Survival
In families kept in the laboratory, four families showed above 70% survival from
June through August (Table 3). Families PG-14, PG-2, PG-6, and PG-1 had the highest
survival (100%, 89%, 85%, and 71% respectively). All other families had less than 50%
survival with PG-21, PG-24, and PG-10 having survival less than 30%. In the field
exposures, the same families exhibited the highest survival (Table 3). The six remaining
families demonstrated survival consistently below 40%. PG-21 appeared to be the most
susceptible, exhibiting a survival of only 3%. In all families, with the exception to PG-24
and PG-10, laboratory-held animals exhibited higher percent survival than their
counterparts in the field.
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Families PG-14, PG-1, PG-2, and PG-24 maintained the lightest infections of P.
marinus from June through August (Figure la). Also, PG-14 and PG-2 had the highest
mean PI of all families (1177 and 1302 ng ECP inhibited, respectively), although PG-1
had the fourth highest mean PI (956 ng ECP inhibited) (Figure lb). PG-24 had the
lowest PI at 204 ng ECP inhibited. Families that appeared to be most susceptible to P.
marinus infections were PG-20, PG-10, and PG-26 (Figure la). Overall, the inverse
correlation among families between infection level (median Mackin score) and protease
inhibitory activity (median PI) was suggestive but not statistically significant (r = -0.41, p
= 0.24).
To demonstrate more clearly the differences between the families, family-specific PI
values were plotted against survival in the laboratory (Figure 2). The correlation between
family mean PI and survival was significant (r= 0.685, p = 0.029). Interestingly, PG-10
exhibited high PI, yet had low survival in the laboratory and in the field. Conversely,
PG- 6 exhibited high survival, yet had only moderate PI.

Relationship of PI to Disease Intensity
To correlate PI with Mackin scale, individual oysters, irrespective of family, were
plotted with their Mackin scale scorings versus their PI (Figure 3). Regression of PI
against Mackin scale indicated a negative correlation (r = -0.31). The relationship
between Mackin scale and PI was weak (r2 = 0.096), however, the result was still highly
significant (p < 0.0005). One-way ANOVA and a Tukey’s multiple comparisons test
detected a significant difference in PI between negatively and heavily infected oysters (p
< 0.005 and p = 0.005, respectively).
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Discussion
There appear to be distinct differences between the selectively bred oyster families
with regard to PI and susceptibility to P. marinus infections. Preliminary diagnosis o f P.
marinus infections revealed differences in prevalence and intensity between families.
Some families such as PG-14, PG-1, and PG-2 had rare infections prior to the experiment
(Table 2) and maintained either rare or light infections throughout the study. Conversely,
families PG-20, PG-10, and PG-26 were diagnosed with light or moderate infections
prior to the experiment (Table 2) and infections intensified to moderate and
moderate/heavy. It is interesting to note that some MSX-resistant parental stocks were
used to generate the families, however, low P. marinus susceptibility was observed in
some of these families. Thus, although the occurrence of moderately and heavily Dermo
infected families that have MSX-resistant parents is consistent with the findings by
Chintala and Fisher (1989) and Burreson (1991), such parents can yield seemingly
Dermo-resistant progeny. A difference between laboratory and field survival in the
families was also detected (Table 3), however, this would be expected. The lower
survival of families in the field may have been reflective of the sustained challenge over a
longer time period to P. marinus in the field or exposure to other pathogens.
Three of the four families that exhibited low disease intensity, PG-14, PG-1, and PG2 also exhibited high PI. Two o f the three families with the highest disease intensity, PG20 and PG-26, also exhibited low PI (Figure la and lb). It is possible that elevated PI

49

played an important role in suppressing P. marinus infections in PG-14, PG-1, and PG-2
by inhibiting pathogen proteases while the lower PI in PG-20 and PG-26 resulted in
higher susceptibility. Although no definitive cause and effect relationship can be
concluded from this association, it is suggestive that either PI is responsible for limiting
or preventing P. marinus infections, or protease inhibitors are the targets of P. marinus
infections. Alternatively, it is possible that under heavy infection pathogen proteases
deplete the host repertoire o f inhibitors by forming protease-inhibitor complexes. It is
possible that under heavy P. marinus infections, the pathogen may destroy or suppress an
oyster’s ability to produce inhibitors. In a study by Ford (1986), a dramatic decline in
hemolymph protein concentration in MSX-susceptible oysters was observed with a
concurrent increase in MSX intensity. Ford suggested that such a depression in
hemolymph proteins was due to long-term systemic parasitism and that their loss during
H. nelsoni infections reflected their overall importance to the health of the oyster.
Because of the low prevalence of H. nelsoni in preliminary diagnoses, it cannot be
precluded that MSX may play a minor role in affecting the PI levels observed in the
experiment. However, such a proviso would have to be made for all possible pathogens
and commensals, even under the most stringent of culture conditions.
The production of phenotypically variable families of oysters enabled us to
determine if a relationship existed between PI and disease intensity. When average
family Mackin scale values were compared to their respective PI levels, an inverse
correlation was observed (Figure la and lb). This correlation, however, was only
suggestive and was not statistically significant. One factor that might have confounded a
significant relationship might have been previous exposure to other pathogens.
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This correlation, albeit not statistically significant, prompted us to explore the
relationship between PI and disease intensity, irrespective of family. Box plots of
individual oysters, grouped according to their Mackin scale scoring and plotted versus its
PI, showed a negative correlation between the two (Figure 3). Furthermore, one-way
ANOVA and multiple comparison tests revealed a significant difference in PI between
the negatively and heavily infected oysters. The negative correlation between disease
intensity and PI, as well as the difference between the negative and heavy infections,
further supports the hypothesis that PI may be an important defense factor in fighting P.
marinus infections.
Other studies have attempted to identify biochemical and cellular correlates of
disease resistance in C. virginica. In a study by Ford (1986), hemolymph proteins from
MSX-resistant and susceptible C. virginica were compared after exposure to H. nelsoni.
Ford attempted to correlate disease resistance with changes in serum protein by
comparing electrophoretic profiles of oysters from both groups. Ford observed
variability in the electrophoretic profiles with no definitive differences in banding
patterns between the resistant and susceptible groups being discerned. Chu and La Peyre
(1993) compared three separate stocks of oysters to determine differences in specific
humoral and cellular responses to P. marinus challenge. They observed the lowest
cumulative mortality and the highest serum protein and lysozyme concentration in the
Deep Water Shoals (DWS) stock (James River, VA). Also, the percentage of
granulocytes in the DWS stock was greater than that in the other groups. Chu and La
Peyre speculated that this difference might have provided the DWS stock with a
physiological advantage over the other groups, rendering them less susceptible to
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infection. In another study, Ling (1990) observed an increase in hemocyte numbers
(hemocytosis) in MSX-resistant oysters compared to MSX-susceptible oysters when
challenged with H. nelsoni.
Protease inhibitors have been identified in a number of molluscan species
(Armstrong and Quigley, 1992), however, they have not been implicated in disease
resistance in marine molluscs. In a study by Fryer et al. (1991), resistant strains of the
snail, Biomphalaria glabrata, exhibited significantly higher PI to the trematode,
Schistosoma mansoni, than did susceptible strains. The endogenous PI may not
necessarily be responsible for resistance in strains of B. glabrata since the PI was
assessed by its activity against commercial proteases and not proteases of S. mansoni.
Teleost protease inhibitors have also been suggested as important mediators of disease
resistance. In a study by Ellis (1991), an a 2 -macroglobulin-like molecule was purified
from rainbow trout (Oncorhynchus mykiss) sera and its neutralizing activity demonstrated
against a protease of Aeromonas salmonicida, a major virulence factor o f the pathogen.
Freedman (1991) compared the a 2 -macroglobulin-like neutralizing activity in rainbow
trout and brook trout (Salvelinus fontinalis) to A. salmonicida and found that brook trout,
which are more susceptible to furunculosis, exhibited lower activity.
Despite the biochemical or cellular correlations drawn by previous investigators, the
need to identify definitive markers of resistance still remains. Our results demonstrate
that among genetically diverse and phenotypically distinct families of oysters, differential
resistance to P. marinus infections can be correlated with levels of endogenous protease
inhibitors. This association suggests that PI may serve as an indicator or marker o f
disease resistance.
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Table 1. Lineages o f ten oyster families selected for Dermo resistance. Origins o f each
parental female and male are listed.

Family

Parental Female

Parental Male

PG-1

F7 MSX disease resistant
line (Delaware Bay) 1

Fi CROSBreed line2

PG-2

Fi CROSBreed line

F7 MSX disease resistant
line (Delaware Bay)

PG-6

PG-10
PG-14

Maine wild type x F7 MSX
disease resistant line
(Delaware Bay)
Maine wild type x F7 MSX
disease resistant line
(Delaware Bay)
Maine stock x F7 MSX
disease resistant line
(Delaware Bay)

Louisiana wild type
Maine stock x F7 MSX
disease resistant line
(Delaware Bay)
Texas wild type x Maine
wild type

PG-18

Naturalized Oregon stock3

Alabama wild type x Maine
wild type

PG-20

Naturalized Oregon stock

Alabama wild type x Maine
wild type

PG-21

Maine wild type

Fi CROSBreed line

PG-24

Fi CROSBreed line

Maine wild type

Maine wild type

F6 MSX disease resistant
line (Delaware Bay) x F5
MSX disease resistant line
(Long Island) 4

PG-26

- Vrijenhoek et al., 1990.
- CROSBreed lines were produced by mating several MSX resistant lines so that any
one progeny was a hybrid of two MSX resistant lines as described by Vrijenhoek et al.,
1990.
- Oysters were imported from the east coast of the U.S. to the west coast and have been
kept there for an unspecified number of generations. Their original genetic origin is
unknown.
4 - Disease resistant lines were produced from either Delaware Bay survivors or from
survivors of Long Island stocks (transplanted to Delaware Bay) (Haskin and Ford, 1987).
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Figure Legends
Figure la. Levels of hypnospore number per family. Bars represent mean disease
intensity for laboratory held oysters. Error bars represent standard error. Values for the
Mackin Scale are: 0 - negative, 0.5 - rare, 1.0 - light, 2.0 - light to moderate, 3.0 moderate, 4.0 - moderate to heavy, 5.0 - heavy. (Mackin, 1962).

Figure lb. Levels of low molecular weight (LMW) PI. Bars represent mean PI (ng ECP
inhibited/50 pi plasma) for laboratory held oysters. Error bars represent standard error.

Figure 2. Relationship between mean family PI value and family survival (June through
August 1998). Error bars = standard errors of mean PI values. The correlation between
family mean PI and survival was significant (r = 0.685, p = 0.029)

Figure 3. Correlation between Mackin Scale and PI for June and August 1998.
Individual oyster Pis were plotted versus their respective Mackin Scale scoring
it,

iL

t

t

irrespective of family. Shaded boxplots represent the 25 and 75 percentile. The solid
line within each boxplot represents the median and the dotted line represents the mean.
tVi
tfi
Plotted points represent data that lie outside the 5 and 95 percentile (error bars).
Results indicated a significant negative correlation (r = -0.31, p < 0.0005), however, the
correlation coefficient was low (r2 = 0.096). Asterisks denote a significant difference in
PI between negatively and heavily infected oysters (p < 0.005 and p = 0.005,
respectively) via one-way ANOVA and Tukey’s multiple comparisons test.
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Chapter 3

Protease inhibitory activity to the oyster pathogen, Perkinsus marinus,
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Abstract
A selectively bred eastern oyster stock (Crassostrea virginica), exhibiting marked
resistance to the two primary oyster pathogens of the Chesapeake Bay, Haplosporidium
nelsoni (MSX) and Perkinsus marinus (Dermo), as well as unselected stocks were
analyzed for protease inhibitory (PI) activity to virulence factors of P. marinus to
determine if any correlations could be discovered between disease susceptibility to
Dermo and PI activity. Disease susceptibility was quantified by the degree o f survival
and the level of P. marinus intensity. These parameters and PI activity were measured in
an F4 generation of MSX/Dermo-resistant stock originating in Delaware Bay (DEBY),
and two, FI generation endemic control stocks originating in Mobjack Bay, VA (MOBY)
and Tangier Sound, VA (TAGR). Samplings were conducted at three salinity sites in the
spring and summer to determine if these environmental conditions would result in
differences in P. marinus infection intensity. Results showed that the resistant stock
(DEBY) exhibited higher growth and survival, and maintained lighter P. marinus
infections than the control stocks at all sites and times. PI activity, however, was variable
among all groups, and DEBY did not consistently exhibit higher PI activity with respect
to the control stocks. As disease intensity increased over time, PI activity decreased in all
stocks with the exception of the stocks held in the high salinity regime (30+ ppt).
Furthermore, PI activity was found to negatively correlate with disease intensity, within
and among all stocks.
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Introduction
Perkinsus marinus is a protozoan pathogen of the eastern oyster, Crassostrea
virginica, and is the causative agent of Dermo (Andrews, 1988). Over the past 30 years
this pathogen, along with Haplosporidium nelsoni, the causative agent in MSX (Ford and
Haskin, 1982) has had a severe economic impact on the commercial oyster fishery in the
Chesapeake Bay. Between 1960 and 1994, commercial landings fell from 3 million
bushels per year to less than 100,000 bushels per year (Burreson and Ragone Calvo,
1996). Strategies to restock oyster populations have included producing and planting
putatively disease resistant oysters from selective breeding programs. For example,
stocks of oysters that survived and grew unhindered under heavy MSX exposure were
bred with other high performance stocks in an effort to propagate resistant oysters
(Haskin and Ford, 1979). Moderate success has been made in selecting and propagating
MSX-resistant oysters in the Chesapeake Bay, however, there has been little success in
breeding Dermo-resistant lines through similar programs (Gaffney and Bushek, 1996).
One impediment in producing Dermo-resistant lines has been the inability to
simultaneously select for resistance to both pathogens. It has been observed that co
resistance does not always arise through selective breeding (Gaffney and Bushek, 1996).
Rather, decreased susceptibility that arises to one pathogen can be accompanied with
continued susceptibility to the other pathogen. Examples of the latter have been observed
in MSX-resistant stocks that continue to express susceptibility to Dermo (Chintala and
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Fisher, 1989; Burreson, 1991). These results, however, were not unprecedented since
selection for resistance to one disease does not necessitate resistance to another disease
(Fevolden et al., 1992). Conversely, Ragone-Calvo et al. (1997) demonstrated decreased
susceptibility of selectively bred oysters to both H. nelsoni and P. marinus. A Delaware
Bay (DEBY) F3 generation was found to have significantly lower mortality and faster
growth than control oysters susceptible to both pathogens.
Another impediment to the production and verification of Dermo-resistant lines is
the lack of knowledge o f the factors that constitute Dermo resistance in oysters.
Underlying factors o f disease resistance may be genetic, but resolution of that would
require access to a phenotypically diverse population with respect to such a trait. It is
thought that by attempting to generate a broad repertoire of phenotypes in oysters, the
chances of distinguishing resistant stocks would be greater (Gaffney and Bushek, 1996).
However, a selection parameter such as survival has limitations due to the slow growth of
oysters and the chronic nature o f Dermo. Therefore, markers for disease resistance that
can be identified early in the development of an oyster would be attractive alternatives.
Protease inhibitors have received recent attention as important defensive factors
against invading pathogens o f finfish (Freedman, 1991; Ellis, 1991; Sleasman et al. 1999)
and have been implicated as important humoral defense factors in a number o f marine
molluscs (Armstrong and Quigley, 1992; Bender and Bayne, 1992; Thorgersen et al.,
1992; Elsayed et al. 1999). One defensive role of protease inhibitors is neutralization of
pathogen proteases. This is particularly germane to Dermo in eastern oysters as serine
proteases of P. marinus have been detected in vitro (La Peyre and Faisal, 1995; La Peyre
et al., 1995) and in vivo (Ottinger et al., unpubl. data) and Garreis et al. (1996) have
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shown that proteases of P. marinus could impair certain oyster defense parameters in
vitro. Thus, their role in oyster humoral defense has been suggested by Faisal et al.
(1998) and Oliver et al. (1999). Additionally, protease inhibitory activity (PI) has been
correlated with disease intensity in selectively bred oyster families (Oliver, M.S. thesis,
chapter 2).
The production of Dermo-resistant oysters would provide an opportunity to study
the relationship between PI activity and disease susceptibility. Efforts by Ragone-Calvo
et al. (1997) have led to the production of another MSX/Dermo-resistant DEBY F4
generation (pers. comm., Ragone-Calvo, 1999). This stock and two control stocks were
deployed for field trials from 1997-1999 at three different salinity regimes (low,
moderate, and high). Preliminary data showed the resistant stock, DEBY, to have
significantly greater growth and survival than the control stocks (Ragone-Calvo, Calvo,
and Burreson, pers. comm.) at all salinity sites. Additionally, intra-specific Dermodisease intensity of DEBY was significantly lower than control stocks. Other than
growth, survival, and disease intensity, the development of other correlates o f resistance
have not as yet been attempted.
This study was initiated to determine if a relationship between PI activity and disease
susceptibility existed in the three stocks of oysters described above.

Materials and Methods
Oysters
From August 1997 to July 1999, an F4 generation of oysters (DEBY), originating
from the selective breeding of an MSX/Dermo-resistant line at VIMS (DB) (Ragone-
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Calvo et al., 1997) were evaluated along with two indigenous FI generations of oysters
from Mobjack Bay (MOBY) and Tangier Sound (TAGR), Virginia. Oysters were
deployed in three separate salinity regimes in the Chesapeake Bay (high salinity, 30+ ppt
- Burton Bay, VA, near Wachapreague, VA; moderate salinity, 15-25 ppt - York River,
VA, Gloucester Point; low salinity, 10-15 ppt - Great Wicomico River, VA) and
monitored for percent survival, shell height, and prevalence of P. marinus. This study
was performed in conjunction with the monitoring of the three stocks between May and
July 1999. Growth (shell height in mm) and mortality were measured in May and July at
all sites. Twenty oysters from each stock were sampled from each salinity site in May and
July 1999 to assess environmentally-dependent differences in Dermo intensity. Oysters
were notched and 1 ml of hemolymph drawn for PI determination and oysters sacrificed
to determine the prevalence and intensity of P. marinus infections.

Hemolymph
Oysters were notched using a radial saw and bled for hemolymph. One milliliter
aliquots of hemolymph were removed from oyster adductor muscles using 5-cc syringes
and 25-gauge needles. Hemolymph samples were centrifuged at 4 °C at 400 x g to pellet
the cells and debris. Cell-free hemolymph (plasma) was filtered through a 0.22-jam
syringe-top filter (Costar Scientific Corp., Cambridge, MA). Plasma was centrifuged in a
Microcon-10 apparatus (Amicon Inc., Beverly, MA) to isolate low molecular weight
plasma components (<10 kDa). The filtrate was frozen at -20°C until further use.

Dermo Diagnosis
Immediately following bleeding, oysters were shucked and gill, mantle, and rectal
tissues were sampled for presence of Perkinsus marinus. Diagnosis was performed using
Ray’s Fluid Thioglycollate Method (RFTM) (Ray, 1952, 1966) and infections scored
according to the method described by Mackin (1962).

Protease Inhibitory Activity
Protease inhibitory activity within oysters was detected and quantified using a
modified Hide Powder Azure method described by Bender et al. (1992). A standard
curve of P. marinus proteolytic activity was prepared in a 96 well microtiter plate
(Costar) using undiluted, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, and 1:128 dilutions of
extracellular proteins (ECP) containing serine protease. ECP was derived from in vitro
propagated cultures o f P. marinus following the procedure of La Peyre et al. (1995). All
dilutions used in the standard curve were made using cold (4°C) artificial seawater (Forty
Fathoms Marine Mix Artificial Sea Water, 22 g/L) and kept on ice. Four microliters of
each dilution from the standard curve were added to wells in triplicate followed by 50 pi
of room temperature artificial seawater. Fifty-four microliters of room temperature
artificial seawater were added as a blank. Four microliters of undiluted protease were
added to separate triplicate wells followed by addition of 50 pi low molecular weight
oyster plasma. Negative controls consisted of 54 pi plasma only. Mixtures of protease
and plasma were incubated at room temperature for 15 minutes on a shaker. Following
incubation, lOOpl of Hide Powder Azure substrate suspension (0.02 g/ml, 150 mM Tris,
30 mM CaCb, 0.05% Brij, 20% sucrose, pH 7.5) was added to each well. Plates were
incubated at 37°C on a shaker for an additional 3 hours. After incubation, 100 pi of cold
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artificial seawater were added to each well to stop the reaction. Plates were centrifuged
at 2700 x g for 15 minutes at 4°C. One hundred microliters of supernatant were removed
from each well and transferred to another 96 well microtiter plate. Plates were read at
540 nm on a Titertek® Multiskan® MCC/340 plate reader (Labsystems, Finland) using
DeltaSof! 3 software (BioMetallics, Inc., Princeton, NJ). Based on the protease standard
curve, reduction in A 5 4 0 due to the inhibition by LMW C. virginica plasma was calculated
and expressed as ng ECP inhibited/50 pi LMW plasma.

Statistics
Mean shell height, percent survival, RFTM, and PI activity were calculated and
plotted for each stock at all sites. Shell height and percent survival data was also
expressed as the change in shell height (mm) and percent increase in mortality
respectively. RFTM and PI activity were compared for all stocks via paired t-tests (p =
0.05) (Minitab, Minitab, Inc., State College, PA). The PI activity and RFTM for
individual oysters, irrespective o f stock and site, was plotted and linearly regressed.
Percent survival and mean PI activity for each stock was plotted and compared using a
linear regression (Sigma Plot 4.0, SPSS, Inc., Chicago, IL). Mean stock-specific PI and
RFTM were plotted and linearly regressed.

Protein Determination
Protein determinations were made for July plasma samples using the BCA Protein
Assay Kit (Pierce, Rockford, IL). Mean protein concentrations (mg/ml) were plotted for
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each stock within each site. Additionally, individual oysters were pooled according to
their RFTM value and plotted against their respective protein concentration.

Results
Growth and Survival
Growth (shell height in mm) of each stock is shown in Figures la and lb. The
MSX/Dermo-resistant line, DEBY, exhibited the best growth at all sites from May to July
with the exception of the YR TAGR stock that exhibited slightly better growth than YR
DEBY (Figure lb). The greatest increase in growth for DEBY occurred at the GWR site.
In terms of mortality, DEBY exhibited lower mortality than the control stocks at all
sites from Nov. 1998 to May 1999 and May to July, 1999 (Figure 2a). The percent
mortality of DEBY from May to July was also lower than the control stocks at all sites
with the exception of YR MOBY where the percent mortality was the same (Figure 2b).

Dermo Disease Intensity
Dermo disease intensity and prevalence was measured for each stock at all sites and
plotted as mean intensity on the Mackin Scale (Figure 3a). Results show DEBY to have
the lowest intensity in May and July at all sites compared to the control stocks. In May,
DEBY did not exhibit an infection intensity above that of a rare infection and the
prevalence was greatest at 25% (BB). In July, infections intensified slightly and the
prevalence increased in DEBY at all sites, however, infection intensity did not rise above
rare or light infections. In a similar manner, the control stocks displayed low infection
intensity and prevalence in May. However, in contrast to DEBY, infection intensity

increased dramatically in July. Minimally, infections rose to light/moderate infections
(GWR MOBY, BB TAGR) and maximally, rose to moderate infections (GWR TAGR,
YR TAGR). Intra-stock paired t-tests were performed and results indicated significant
increases in disease intensity (p<0.05) at each site for all stocks. Over the course of the
study, one-way ANOVA showed infections in DEBY were significantly lower (p<0.001)
than the control stocks at GWR and YR, thus supporting our hypothesis that DEBY
would exhibit less infection intensity than the controls. However, at BB the difference
between DEBY and the controls was not significant (p = 0.087).

Protease Inhibitory Activity
Protease inhibitory activity was measured for each stock at all sites and plotted as
mean PI (Figure 3b). Results showed variability among stocks for May and July. DEBY
did not show uniformly greater PI than the control stocks either in May or July with one
exception. At GWR in July, DEBY exhibited significantly higher PI than the controls.
DEBY exhibited greater PI at YR in May; however, it was not significantly different
from the controls.
PI activity did not increase over time as disease intensity increased. Rather, PI
activity decreased from May to July in all groups with the exception of BB MOBY and
TAGR where PI increased. Paired t-tests were performed at each site for each stock to
determine differences between May and July time points. The control stocks exhibited
significant decreases in PI activity (p<0.05) at GWR and YR. In contrast, PI activity in
the DEBY stock did not decrease significantly at either site. At BB, PI activity increased
significantly (p<0.05) for MOBY, but the increase was not significant for TAGR. DEBY
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PI decreased, however, the result was not significant. There appeared to be a salinity
effect on PI in May as BB PI was lower for all groups compared to GWR and YR. The
salinity effect appears to have diminished in July as PI was not considerably different
from the other sites.

Correlation of PI Activity with Survival and RFTM
Individual oysters were scatter plotted according to their respective PI activity and
RFTM and the result linearly regressed (Figure 4). A trend of higher PI with lower
RFTM was observed
(r = -0.25) (p<0.0001), however, the correlation coefficient was too low to suggest any
predictable relationship between PI and disease intensity (r2 = 0.06).
Mean stock PI and percent survival were plotted and the result linearly regressed
(Figure 5). The low correlation coefficient (r2 = 0.02) indicated that there was no
relationship between the two. A slight negative correlation was detected (r = -0.14),
however, the result was not significant.
Mean stock PI and disease intensity on RFTM were plotted and the result linearly
regressed (Figure 6). The correlation coefficient was low (r2 = 0.13) suggesting that PI
accounts for only a small proportion of the variability in disease intensity. A negative
correlation between PI and disease intensity was observed (r = -0.36).

Protein Determination
Oysters from GWR and YR sites exhibited higher protein concentrations than oysters
from the BB site (Figure 7). This result is not surprising and it is likely a salinity effect
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as each o f these stocks were bred for an optimal salinity below that observed at BB
(Calvo, pers. Comm.). No significant differences were detected between stocks within
each site. When individual oysters protein values were plotted with respect to their
RFTM, no significant differences were observed (Figure 8). Unlike PI activity, there was
no apparent trend of lower protein concentration with higher Dermo intensity.

Discussion
This study was initiated to determine whether a biochemical factor, such as protease
inhibitory activity, could be directly correlated with Dermo disease resistance. The
parameters used to measure resistance are based solely on survival and the degree of
infection. At present, there are no genetic or biochemical factors or predictors of Dermo
resistance. There is, however, strong evidence that the conferring of Dermo resistance is
genetic (Gaffney and Bushek, 1996). Most of this evidence comes from the decades of
selective breeding practices o f oysters resistant to MSX (Haskin and Ford, 1979; Ford
and Haskin, 1987; Gaffney and Bushek, 1996).
Understanding the mechanisms of pathogenesis can lead to the identification of
important host defense markers. La Peyre and Faisal (1995) and La Peyre et al. (1995)
observed the secretion of serine proteases by P. marinus into the culture medium and
speculated that they may be important molecules in the pathogenesis. Previous work by
Oliver et al. (1999) demonstrated that eastern oysters possess low molecular weight
inhibitory activity directed against these suspected virulence factors of P. marinus.
Specifically, low molecular weight plasma constituents (8-10 kDa) were observed to
inhibit P. marinus serine protease digestion of a specific host plasma protein in vitro.

Based on this observation, it was hypothesized that the observed anti-proteolytic activity
in eastern oysters might serve as a biochemical marker for Dermo resistance.
The selective breeding o f MSX/Dermo-resistant oysters (DEBY) at VIMS provided
us with an opportunity to correlate PI with Dermo resistance. In addition, the production
of two control stocks endemic to the Chesapeake Bay which were believed to be
susceptible to P. marinus (MOBY and TAGR) provided an important comparison. It was
our intention to determine if a correlation between PI activity and disease susceptibility
existed in each stock. Survival and Dermo disease data supported previous studies
suggesting that DEBY exhibits apparent disease resistance. DEBY exhibited greater
cumulative growth and appeared to be the least susceptible to Dermo of the three strains
by exhibiting lower mortality and infection intensity. PI activity, however, did not
correlate with these other parameters, as it appeared to be variable. In fact, DEBY PI
activity was often lower than that of the controls in May and July. PI activity did not
increase over time which might be anticipated if this component were inducible. In fact,
PI activity decreased significantly from May to July in the controls at GWR and YR. It is
interesting to note that PI activity in DEBY did not significantly decrease at GWR and
YR.
The discrepancy between PI activity and survival and infection intensity might lead
one to conclude that PI is not a factor in Dermo resistance. However, it is possible that
the sensitivity of the assay may have precluded us from accurately determining protease
inhibitor activity, and thus may have led to an underestimation of the true activity present
in the plasma. First, protease inhibitors of serine proteases operate by binding the active
sites of proteases (Laskowski and Kato, 1980). Serine protease inhibitors are often small
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molecules (370-390 amino acids in length) (Huber and Carrell, 1989). The PI activity
directed against P. marinus serine protease activity found in C. virginica plasma was also
of low molecular weight (8-10 kDa) (Oliver et al., 1999), however, the exact sequence
has not been determined. If protease inhibitors of C. virginica were binding the active
site of P. marinus proteases as suggested by the mechanisms described by Laskowski and
Kato (1980), this would preclude the assay from detecting already bound protease
inhibitors. That is to say, the assay employed herein only detected free or unbound
inhibitors. It is possible that as disease intensity increased from May to July, the amount
of protease also increased. In response to this, free and unbound inhibitors in the plasma
would have become bound to the increasing amounts of P. marinus protease and thus,
would not be detected using the Hide Powder Azure assay. This would account for the
significant decreases in PI activity observed in the control stocks at GWR and YR. The
observation that PI activity in DEBY did not significantly decrease from May to July
suggests that DEBY was able to maintain higher levels of unbound inhibitor. This may
have occurred directly, through induced expression of inhibitors, or indirectly, through a
separate suppressive mechanism of P. marinus proliferation and protease expression. In
either case, the possibility o f PI activity being involved in resisting P. marinus infections
cannot be ruled out. One avenue that can circumvent the possibility of underestimating
protease inhibitor levels is the use of a more sensitive assay. This could either be
antibody-based where a probe could detect free and bound inhibitor, or molecular-based
where mRNA could be detected if such an induction of inhibitor occurred.
These studies are o f particular interest in light of previous studies (Oliver, M.S.
thesis, chapter 2) wherein a strong statistical correlation existed between the level of PI

78

activity and resistance. Results of this study suggest a low correlation between PI
activity and Dermo intensity and PI and survival.
One reason for the lack o f agreement between the results observed by Oliver (1999,
M.S. thesis, chapter 2) and the results observed herein with regard to PI activity and
Dermo intensity might be related to the genetic variability of the oysters. The former
result was observed in ten families of oysters that were produced from oysters with broad
geographical origins (see M.S. thesis, chapter 2, Table 1). The resistant oyster stock
tested in this study originated from several generations of inbred parents and was
compared to control stocks whose parents were simply individuals from endemic oyster
stocks in the Chesapeake Bay (Calvo, pers. comm.). The restricted genetic variability in
these stocks, compared to the more genetically varied families, may have been
insufficient in allowing for a clear relationship between PI activity and disease resistance
to be seen. The less significant difference observed herein between PI activity and
disease resistance does not preclude the importance of PI activity in oysters. Protease
inhibitors, whether as defensive molecules or as targets of P. marinus virulence factors,
are likely still important but may not be the single critical factor in resistance.
Another reason for the low correlation between PI and survival and Dermo intensity
might be the presence of other pathogens in the oyster. For instance, the virulence factors
o f many oyster parasites such as H. nelsoni and H. coastale (SSO disease) are not known.
It is possible that either through direct or indirect routes, these pathogens compromise PI.
This would have no bearing on survival, as the high surviving oysters in this study were
already MSX-resistant. Similarly, PI may have been compromised in low P. marinus
infected oysters. The ability of other pathogens to affect PI might have precluded us
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from observing a clear relationship between PI and Dermo intensity. In this way, the use
of field challenges to P. marinus may not allow for the clear determination o f what role
PI plays in resistance to Dermo. Alternatively, tightly controlled laboratory infections of
uninfected resistant and susceptible oysters using filtered water would resolve the
challenge of having confounding pathogens. Nevertheless, a significant negative
correlation was apparent between PI and Dermo intensity, both within and among stocks.
Plasma protein concentrations of July oysters was determined and analyzed
concurrently with PI activity. This was done to determine if plasma protein concentration
could be correlated with Dermo intensity and if there was an effect of plasma protein
concentration on PI activity. In contrast to the finding that there was a significant
negative correlation between PI activity and Dermo intensity, there was no significant
decrease of plasma protein concentration with higher Dermo intensities. Furthermore,
there were no significant differences in plasma protein concentration between stocks
within each site. However, clear differences in stock-specific RFTM were observed.
When PI activity and protein concentrations are considered together, it appears that
changes in PI activity do not reflect any significant changes in plasma protein
concentration as infection intensity increases. Conversely, this suggests that oysters are
capable of maintaining plasma protein concentration at higher Dermo intensities,
however, they may not be able to maintain PI activity. Thus, it appears that plasma
protein concentration and PI activity are not coupled phenomena during Dermo
infections.
The concept of a biochemical factor(s) contributing to increased disease resistance is
well established. Ford (1986) examined MSX- resistant and susceptible electrophoretic
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hemolymph protein profiles in an attempt to identify protein differences. Additionally,
Chintala and Fisher (1989) noted an association of lower susceptibility with higher serum
lectin concentrations in MSX-resistant oysters compared to native oysters, although no
precise causative relationship was posed. Specifically, protease inhibitors have been
identified in a number of molluscan species (Armstrong and Quigley, 1992) and have
been implicated in disease resistance in the snail, Biomphalaria glabrata, by Fryer et al.
(1991). Fryer et al. showed that resistant strains of the B. glabrata exhibited significantly
higher PI to the trematode, Schistosoma mansoni, than did susceptible strains. The
endogenous PI may not necessarily be responsible for resistance in strains of B. glabrata
since the PI was assessed by its activity against commercial proteases and not proteases
of S. mansoni. Teleost protease inhibitors have also been suggested as important
mediators of disease resistance. Ellis (1991) purified an a 2 -macroglobulin-like molecule
from rainbow trout (Oncorhynchus mykiss) sera and demonstrated its neutralizing activity
against a major virulence factor of the pathogen, a protease of Aeromonas salmonicida.
In a study by Freedman (1991), the oc2 -macroglobulin-like neutralizing activity to A.
salmonicida in rainbow trout was compared to that of brook trout (Salvelinus fontinalis).
Freedman found that brook trout exhibited lower activity and is more susceptible to
furunculosis.
This use of protease inhibitory activity as a correlate of Dermo resistance is
continuing to be explored. The advent of more sensitive assay tools, along with more
tightly controlled infection experiments with P. marinus, may facilitate our understanding
of the role of PI in resisting P. marinus infections. Furthermore, they may provide
insight into understanding oyster humoral defense and P. marinus pathogenesis.
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Figure Legends
Figure la. Mean shell heights (mm) (n = 100) for each stock in May (white) and July
(black) 1999 at each site (GWR - Great Wicomico River, YR - York River, BB - Burton
Bay). Error bars represent the standard error of the mean.

Figure lb. Mean increase in shell height (mm) from May to July 1999. Increase was
based on mean shell heights from May and July (n = 100).

Figure 2a. Percent survival for each stock from Nov. 1998 to May 1999 (white) and from
May to July 1999 (black).

Figure 2b. Percent mortality for each stock from May to July 1999.

Figure 3a. Mean Dermo disease intensity for each stock as rated on the Mackin Scale.
Disease intensity was measured for each stock from a subsample of 20 oysters per stock
in May (white) and July (black) 1999. Error bars represent the standard error o f the
mean. Percentages above each bar reflect the percent prevalence of P. marinus within
each stock. Ratings on the Mackin Scale are noted on the figure. Results showed
significant differences for every stock at each site (p<0.05).

Figure 3b. Mean plasma protease inhibitory activity (PI) (ng ECP inhibited 50 pi
plasma) for each stock in May (white) and July (black) 1999. Error bars represent the
standard error of the mean. Asterisks denote significant differences (p<0.05). One-way
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ANOVA was performed to compare PI within site. Significant differences are denoted
by # (p<0.05).

Figure 4. Scatter plot of individual oyster mean PI (ng ECP inhibited 50 pi plasma) and
Dermo intensity as rated on the Mackin Scale. Oysters were plotted irrespective of stock.
The shaded box represents the 25th and 75th percentiles. The solid line within the box
represents the median the dotted line represents the mean. Error bars represent the 10
and 90th percentiles. Linear regression of PI and RFTM resulted in a negative correlation
(r = -0.25) and a low correlation coefficient of 0.06. The result, however, was significant
(pO.0001).

Figure 5. Mean stock PI (ng ECP inhibited 50 pi plasma) versus stock survival. Error
bars represent the standard error o f the mean. Linear regression of mean PI and survival
resulted in a slight negative correlation between the two (r = -0.14), however the
correlation coefficient was low (r2 = 0.02). The result was not significant at p=0.05.

Figure 6. Mean stock PI (ng ECP inhibited 50 pi plasma) versus mean stock RFTM.
Error bars represent the standard error of the mean. Linear regression of PI and RFTM
resulted in a negative correlation between the two (r = -0.36) with a correlation
coefficient of 0.13. The result was not significant at p=0.05. Ratings on the Mackin
Scale are noted on the figure. Asterisks denote the MSX- and Dermo-resistant stock,
DEBY.

Figure 7. Mean plasma protein concentrations for each stock in July 1999. Error bars
represent the standard error of the mean.

Figure 8. Mean plasma protein concentration for each RFTM rating for July 1999
oysters. Individual oyster protein concentrations were grouped according to its RFTM
rating and means calculated for each rating. Error bars represent the standard error of the
mean. No significant differences were detected.
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Chapter 4

In vivo induction of protease inhibitory activity
in eastern oysters, Crassostrea virginica,
infected with Perkinsus marinus
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Abstract
Three groups o f eastern oysters, Crassostrea virginica, were monitored for protease
inhibitory activity (PI) after challenge with the oyster pathogen, Perkinsus marinus. One
group was challenged with in vitro cultured P. marinus (1 x 106 viable meronts/ml), the
second group was challenged with formalin-treated/heat-inactivated P. marinus (1 x 106
meronts/ml), and the third group was challenged with sterile-filtered artificial seawater.
Hemolymph was obtained at 3 weeks prior to challenge and weeks 1,3, and 5 post
challenge (p.c.) and measured for low molecular weight PI. PI was compared to baseline
levels (3 weeks pre-challenge) of PI for each treatment. Disease intensity for each
treatment was measured via Ray’s Fluid Thioglycollate Method (RFTM) following the
final bleed at week 5. The treatment receiving live P. marinus exhibited, on average, rare
to light infections. The other two treatments were negative for P. marinus infections. PI
activity was analyzed in two ways: 1. PI activity was measured and standardized to
plasma protein concentration (specific PI activity), 2. PI activity was measured with
respect to the volume o f plasma assayed (non-specific PI activity). Results of PI analysis
indicate that PI is inducible upon challenge with live and killed P. marinus as evidenced
by a significant increase in specific PI activity at week 1 p.c. Furthermore, at weeks 3
and 5 p.c. specific PI activity remained significantly higher than the baseline in the
treatment receiving killed P. marinus, whereas PI activity dropped to near baseline levels
in the treatment receiving live P. marinus. No significant increase in PI activity was
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observed in the artificial seawater treatment at any time. Non-specific PI activity in the
live and killed P. marinus treatments also appeared to be induced at week 1 p.c.,
however, PI activity did not remain elevated at weeks 3 and 5 p.c. Rather, PI activity
decreased to near baseline levels. Additionally, non-specific PI activity at weeks 3 and 5
p.c. for the live P. marinus treatment dropped below the baseline.
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Introduction
Perkinsus marinus is a protozoan pathogen of the eastern oyster, Crassostrea
virginica, and is the causative agent in the disease known as Dermo (Andrews, 1988). It
has been the most important oyster pathogen in the Chesapeake Bay since the late 1980’s
and is responsible for massive mortalities in this species (Andrews, 1996; Burreson and
Calvo, 1996). In addition to Dermo, other factors such as overharvesting and destruction
of oyster reefs have resulted in a dramatic decline in Virginia oyster harvests to less than
10,000 bushels per year in the mid-1990’s (Burreson and Calvo, 1996).
One approach to rejuvenating oyster populations has been the selective breeding of
disease resistant oysters. For decades oysters have been selected for resistance to
Haplosporidium nelsoni, the causative agent in MSX (Haskin and Ford, 1979; Ewart et
al., 1988; Matthiessen et al., 1990; Matthiessen and Davis, 1991). Despite the success in
producing generations o f MSX-resistant oysters, co-resistance to Dermo has been not
been observed with any consistency (Chintala and Fisher, 1989; Chintala and Fisher,
1991; Burreson, 1991). Recently, however, an F4 generation of MSX-resistant oysters
produced at the Virginia Institute of Marine Science has exhibited high growth and
survival and low Dermo intensity (Calvo, Ragone-Calvo, and Burreson, pers. comm.).
Although there are currently no genetic markers for disease resistance, there is evidence
to support heritability o f resistance (Ford and Tripp, 1996; Gaffney and Bushek, 1996).
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The biochemical and physiological factors contributing to MSX and Dermo
resistance are not known. Valiulis (1973) suggested there to be a common mechanism of
resistance to both diseases, however, there has been no evidence thus far to support this
(Ford and Tripp, 1996). One approach to understanding the mechanism(s) of resistance
to MSX and Dermo has been to examine cellular and humoral defenses of resistant
oysters. The cellular and humoral defenses of the eastern oyster are well-documented
(Anderson, 1996; Chu, 1988; Feng, 1988; Ford and Tripp, 1996). For example, Ford
(1986) observed a dramatic decline in hemolymph protein concentration in MSXsusceptible oysters with a concurrent increase in MSX intensity when compared to MSXresistant oysters. Ford suggested that such a depression in hemolymph proteins was due
to long-term systemic parasitism and that their loss during H. nelsoni infections reflected
their overall importance to the health of the oyster. Chintala and Fisher (1989) noted an
association of lower susceptibility with higher serum lectin concentrations in MSXresistant oysters compared to native oysters, although no precise causative relationship
was posed. Ling (1990) observed an increase in hemocyte numbers (hemocytosis) in
MSX-resistant oysters compared to MSX-susceptible oysters when challenged with H.
nelsoni. With respect to Dermo, Chu and La Peyre (1993) compared three separate
stocks of oysters to determine differences in specific humoral and cellular responses to P.
marinus challenge. They observed the lowest cumulative mortality and the highest serum
protein and lysozyme concentration in the Deep Water Shoals (DWS) stock (James
River, VA). Also, the percentage of granulocytes in the DWS stock was greater than that
in the other groups. Chu and La Peyre speculated that this difference might have
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provided the DWS stock with a physiological advantage over the other groups and thus
were less susceptible to infection.
Another approach in determining the factors associated with disease resistance is to
examine virulence factors of the pathogen and look for host defense factors which would
counteract them. The culturing of P. marinus (La Peyre et al., 1993) led to the
subsequent detection of extracellular serine proteases in the culture medium (La Peyre
and Faisal, 1995; La Peyre et al., 1995; La Peyre et al., 1996) and in infected oysters
(Ottinger et al., pers. comm.). These proteases have been shown to have detrimental
effects on oyster defense mechanisms (Garreis, 1996; Anderson, 1999). In this vein,
Faisal et al. (1998) and Oliver et al. (1999) postulated that protease inhibitors might be
important factors involved in host humoral defense and Dermo-resistance. Protease
inhibitors have been detected in a number of marine molluscs (Armstrong and Quigley,
1992) and have been implicated in disease resistance in the snail, Biomphalaria glabrata,
(Fryer et al., 1991). They have also been suggested as important factors in disease
resistance in teleosts (Ellis, 1991; Freedman, 1991).
Work by Oliver et al. (M.S. thesis, chapter 2) has implicated low molecular weight
(8-10 kDa) protease inhibitors as important factors in Dermo-resistance in selectively
bred MSX- and Dermo-resistant oysters. During field challenges of three stocks of
oysters, one Dermo-resistant and two Dermo-susceptible, Oliver and Kaattari (M.S.
thesis, chapter 3) observed lower protease inhibitory (PI) activity in more heavily P.
marinus-infQCted. oysters compared to the less infected oysters. Furthermore, as P.
marinus infections intensified, PI activity was observed to decrease significantly in the
susceptible stocks but not in the resistant stock. The reason for the decreased PI activity
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in more heavily infected oysters was unclear. However, Oliver and Kaattari postulated
that PI activity might be directly compromised by P. marinus proteases through
proteolytic digestion or indirectly through suppression of protease inhibitor expression.
Furthermore, Oliver et al. noted the possibility of outside pathogens having adverse
effects on PI activity. Due to these complications, there is a need to describe the
dynamics of PI activity over time, specifically with respect to P. marinus infections
alone.
The purpose of this study was to infect susceptible oysters with P. marinus and
monitor PI activity over the course of five weeks to describe PI activity dynamics.

Materials and Methods
Oysters
Two-hundred market sized oysters (76-100 mm in shell height) were acquired from
the Pemaquid Oyster Company, Inc. (Pemaquid, ME) in January 1999. Oysters were
acclimated to 25 ppt salinity over the course of three weeks in using Forty Fathoms
Artificial Sea Water in ambient filtered York River water. Oysters were held in two,
sixty gallon tanks and water was changed every other day. Water was filtered using two,
one micron pore size polypropylene filters (Filter Equipment Co., Inc., Wall, NJ).
Oysters were fed a diet of 0.3 g algae paste/oyster per day (Thalassosira weissflogii) and
Isochrysis galbana and Chaetoceros calcitrans at a density of 60,000 - 100,000 cells/ml
per day before and during the experiment. Oysters were maintained in this manner until
the initiation of the experiment. Upon arrival, a subsample of 30 oysters was taken for
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determination of P. marinus infection by RFTM (Ray, 1952,1966). All oysters were
diagnosed negative for P. marinus.

P. marinus Culture and Propagation for Challenge
A culture of P. marinus, isolate P-l, was obtained through the generous donation by
Dr. Jerome La Peyre (Louisiana State University). P. marinus was cultured in JLORDP1 chemically defined medium according to the methods described by La Peyre et al.
(1993). Cultures were grown to a density o f 1 x 106 viable cells/ml and cells were
washed, stained, and counted according to the methods described by La Peyre et al.
(1993). A concentration of 1 x 106 viable cells/ml was prepared in sterile-filtered (0.2
pm Costar bottle top filter) artificial seawater (Forty Fathoms Marine Mix Artificial Sea
Water, 22 g/L) and kept at 17°C.
Formalin-treated and heat-inactivated P. marinus cells were generated using the
following protocol. Cultures were grown to a density of 1 x 106 viable cells/ml and
harvested. Cells were centrifuged at 400 x g at 25°C for 20 minutes. Supernatant was
decanted and cells were resuspended in
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ml of filter-sterilized phosphate buffered

saline (PBS) (pH 7.4). Cells were passed through a 10 ml syringe with an 18 gauge
needle to disaggregate cells. Viable cells were stained with neutral red and counted using
a hemocytometer. Cells were centrifuged again at 400 x g at 25°C for 20 minutes.
Supernatant was decanted and cells were resuspended in
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ml of 1 0 % buffered formalin

phosphate. Cells were incubated overnight at 4°C on an end-over-end rotator. Following
the incubation, cells were centrifuged at 400 x g at 25°C for 20 minutes and resuspended
in 10 ml of PBS. This washing procedure was performed two additional times.
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Following the last wash, viable cells were counted again as previously described. The
cell suspension volume was adjusted with PBS to attain a density of 1 x 106 viable
cells/ml. Cells were then heat inactivated in a water bath for 30 minutes at 56 °C. Cells
were washed three times via centrifugation and resuspension as previously described.
Following the final centrifugation cells were resuspended in sterile artificial seawater so
as to attain a density of 1 x

1 0 6

viable cells/ml.

Protease Inhibitory Activity
Protease inhibitory activity within oysters was detected and quantified using the Hide
Powder Azure as a substrate as detailed by Bender et al. (1992). The protocol was
modified for microtiter plate assays. First, P. marinus extracellular proteins (ECP)
containing serine proteases were derived from culture supernatants as described by La
Peyre et al. (1995). A standard curve of P. marinus ECP was generated by assessing
undiluted P. marinus protease and two-fold dilutions (i.e., 1:4, 1:8, 1:16, 1:32, 1:64, and
1:128) in a 96 well microtiter plate (Costar). All dilutions employed in the standard
curve were made using cold (4°C) artificial seawater (Forty Fathoms Marine Mix
Artificial Sea Water, 22 g/L) and were kept on ice. Four microliters of each dilution from
the standard curve was added to wells in triplicate followed by 50 pi of room temperature
(RT) artificial sea water. Fifty-four microliters of artificial seawater at RT was added as
a blank. Four microliters of undiluted protease was added to separate wells in triplicate
followed by 50 pi of low molecular weight (LMW) oyster plasma containing PI activity.
Negative controls consisted o f 54 pi of plasma only. A protease control consisted of 4 pi
undiluted protease plus 50 pi RT artificial seawater. The blank for the protease control
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consisted of 54 pi o f RT artificial seawater only. Mixtures of protease and plasma were
incubated at RT for 15 minutes on a shaker. Following incubation, 100 pi of substrate
suspension (Hide Powder Azure, 0.02 g/ml, 150 mM Tris, 30 mM CaC^, 0.05% Brij,
20% sucrose, pH 7.5) was added to each well. Plates were incubated at 37°C on a shaker
for 3 hours. After incubation, 100 pi of cold artificial seawater was added to each well to
stop the reaction. Plates were centrifuged at 2700 x g for 15 minutes at 4°C. One
hundred microliters of supernatant were removed from each well and transferred to
another 96 well microtiter plate. Plates were read at 540 nm on a Titertek® Multiskan®
MCC/340 plate reader (Labsystems, Finland) using DeltaSoft 3 software (BioMetallics,
Inc., Princeton, NJ). Based on the protease standard curve, reduction in A 5 4 0 due to the
inhibition by LMW C. virginica plasma was calculated and expressed as ng P. marinus
protease inhibited/50 pi LMW plasma.

Challenge Procedure
The experiment was initiated by notching 60 oysters using a radial saw. Notches
were made near the adductor muscle so as to make a small exposure to the mantle cavity.
Individual oysters were placed in 800 ml plastic beakers and acclimated for one week.
Temperature and salinity of the water was maintained at 23°C +/- 2°C and 25 ppt,
respectively, throughout the experiment.
The oysters were separated into three groups of twenty and acclimated. After one
week of acclimation, prebleeds o f oysters were procured in order to establish baseline of
PI values. Oysters were bled via the adductor muscle using a 1 cc syringe and a 1 inch,
25 gauge needle. Oyster hemolymph was immediately transferred to a 1.5 ml centrifuge
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tube on ice. Care was taken in rinsing the needle in deionized water between bleeds.
Hemolymph was centrifuged at 400 x g for 10 minutes at 4°C. The cell-free portion, or
plasma, was then centrifuged in a Microcon-10 apparatus (Amicon Inc., Beverly, MA) to
fractionate low molecular weight plasma (<10 kDa). The filtrate containing less than 10
kDa molecules was stored at -20°C until further use.
Three weeks later each group o f oysters was challenged with either 1 x 106 live P.
marinus cells, 1 x 1 0 formalin-treated/heat-inactivated P. marinus cells, or 1 ml of sterile
artificial seawater via mantle cavity injections following the procedure described by
Bushek et al. (1997). Oysters were challenged every other day for a total o f 4 days.
Oyster hemolymph was sampled at 1, 3, and 5 weeks post-challenge (p.c.) using the
methods previously described. Following the last bleed at week 5 p.c. all oysters were
sacrificed for diagnosis of P. marinus infections.

Protein Determination
Protein determinations were performed for all oysters throughout the experiment.
Protein concentration (mg/ml) was determined using the BCA Protein Assay Kit (Pierce,
Rockford, IL).

Disease Diagnosis
Diagnosis of P. marinus infections was performed using Ray’s Fluid Thioglycollate
Method (RFTM) (Ray, 1952, 1966) and infections were scored according to the method
described by Mackin (1962).
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Results
Disease Diagnosis
All oysters were diagnosed for P. marinus infections after the final bleed (data not
shown). The P-l treatment showed 63% prevalence of P. marinus with an average
intensity of 0.63 on the Mackin scale.

Protease Inhibitory Activity
The analysis o f PI activity for each treatment is presented in Figures lb and lc.
Specific PI activity increased significantly (p<0.001) for both live and killed P. marinus
treatments at week 1 (Figure lb). Specific PI activity decreased at week 3 and stabilized
at week 5 in the live P. marinus treatment to just above the baseline. In contrast to the
live P. marinus treatment, specific PI activity in the killed P. marinus treatment remained
significantly higher than the baseline at weeks 3 and 5 (Figure lb). No significant change
in specific PI activity relative to the baseline was observed in the treatment receiving
artificial seawater.
There was considerable variation in baseline levels of non-specific PI activity as the
P-l treatment had the highest baseline level PI followed by ASW and P-1C treatments
(Figure lc). This variability in non-specific PI activity has been consistently observed in
a variety of studies (Oliver et al., M.S. thesis, chapter 2; Oliver and Kaattari, M.S. thesis,
chapter 3). In the P-l treatment, PI increased at week 1 p.c. and then steadily decreased
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at weeks 3 and 5. The PI activity at weeks 3 and 5 was lower than the baseline with week
5 PI activity being significantly lower (p<0.001). The P-l control treatment (P-1C) also
exhibited a similar trend as the P-l treatment. Non-specific PI activity at week 1 was
significantly higher (p<0.001) than the baseline with a marked decrease to near baseline
levels at week 3. In contrast to the P-l treatment, P-1C PI activity did not continue to
decrease at week 5. Rather PI activity remained close to the level of week 3.
Furthermore, the PI activity at weeks 3 and 5 were slightly higher than the baseline, but
they were not significant. Non-specific PI activity in the artificial seawater control
(ASW) exhibited a similar trend as the first two treatments. There was an increase in PI
activity at week 1 with PI activity decreasing at weeks 3 and 5. Similar to the P-1C
treatment, week 3 PI activity dropped to near the baseline level, however, it continued to
decrease at week 5. Interestingly, the PI activity at week 5 was lower than the baseline
that was also seen in the P-l treatment.
Changes in PI activity relative to the baseline of each treatment were plotted in
Figures 2a and 2b. In this way the treatment-specific changes in PI could be more easily
seen.

Plasma Protein Concentration
All treatments exhibited decreases in plasma proten concentration during the
experiment (Figure la). Decreases in plasma protein concentration might be explained
by the change in food quality between the time oysters were received and the final bleed.
Oysters were only fed three algal types during the experiment and may have suffered
nutritional deprivation as reflected in the plasma protein levels.
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Discussion
Eastern oysters are known to have numerous humoral defense factors (Chu, 1988;
Anderson, 1996; Ford and Tripp, 1996). Some of the best studied are the lectins
(McDade and Tripp, 1967a; Olafsen, 1988; Vasta, 1991) and lysosomal enzymes
(McDade and Tripp, 1967b; Cheng and Roderick, 1975; Chu and La Peyre, 1989).
Recently, protease inhibitors have received attention as important defense factors during
P. marinus infections (Faisal et al. 1998; Oliver et al. 1999a) as well as a general
molluscan defense mechanism (Armstrong and Quigley, 1992; Bender and Bayne, 1992,
1996; Thorgersen et al., 1992; Elsayed et al., 1999). Their role in Dermo-resistance has
also been suggested (Oliver et al., 1999b). Oliver et al. (1999b) examined field oysters
exhibiting a wide range of Dermo-resistance and found that low molecular weight
(LMW) protease inhibitory (PI) activity was positively correlated with survival.
Additionally, Dermo intensity as measured on the Mackin scale was negatively correlated
with PI. The latter correlation was significant; however, it was unclear whether P.
marinus was the lone factor in altering PI. One reason Oliver et al. offered was the
possibility that other pathogens might participate in suppressing PI. Furthermore, Oliver
et al. could not determine if and how PI activity varied during the course of a P. marinus
infection. Therefore, this study was intended to elucidate the dynamics of LMW PI
activity during a controlled experimental infection with P. marinus.
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Results of the P. marinus challenge experiment showed a variation in the resting or
baseline levels of specific and non-specific PI activity in susceptible oysters. Due to the
variation in baseline PI between each treatment, comparison of absolute PI activity
between treatments after challenge could not be made. Instead, the change in PI activity
from the baseline was made for each treatment and compared. An increase in specific PI
activity was observed after challenge at week 1 with live P. marinus (P-l) and formalintreated/heat-inactivated P. marinus (P-1C). No significant increase in specific PI activity
was observed in the artificial seawater treatment. P. marinus cells possess membraneassociated proteases as well as having the ability to secrete proteases into the
extracellular medium (La Peyre et al., 1995; M. Faisal, pers. comm.). Therefore, it would
not seem surprising that PI would be induced even in the presence of formalin fixed P.
marinus cells. Thus it would appear that PI is inducible and the induction may be antigenspecific to protease.
Non-specific PI activity exhibited different dynamics than specific PI activity. Like
specific PI activity, non-specific PI activity increased in both the live and killed P.
marinus treatments at week 1. The increase in the P-l challenge was not significant and
the increase in the P-1C challenge was significant. However, in contrast to specific PI
activity, non-specific PI activity decreased below baseline levels in the P-l challenge and
decreased to near baseline levels in P-lC challenge at weeks 3 and 5. Challenges with
artificial seawater also appear to have elicited a response in non-specific PI activity. It is
possible that oysters may be hypersensitive to the injection process and seawater alone
can elicit a PI activity response. It is otherwise unclear why such an induction o f PI
activity would occur in this treatment.
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It is interesting to note the decline in non-specific PI activity in all treatments
observed herein. One reason for the decline in non-specific PI activity may be that
plasma protein concentrations also decreased. Previous studies have noted the
association between plasma protein and disease intensity (Ford, 1986; Chu and La Peyre,
1993). Specifically, inverse associations between plasma protein concentrations and
susceptibility have been observed. This inverse association was not observed by Oliver
and Kaattari (M.S. thesis, chapter 3) with respect to non-specific PI activity and Dermo
infection. Rather, Oliver and Kaattari found no association between Dermo intensity and
plasma protein concentration since there was no significant difference in plasma protein
at any scoring of the RFTM scale. They suggested that PI activity was not coupled to
plasma protein dynamics. This assertion is supported by the observation herein that non
specific PI activity does not appear to exhibit any predictable pattern with respect to
plasma protein concentration. These findings challenge the appropriateness of
standardizing PI activity to plasma protein concentration. Changes in plasma protein
concentration may bias specific PI activity as lower protein my skew PI activity higher.
Conversely, higher protein may skew PI activity lower.
The continual decrease in non-specific PI activity in the P-l treatment and the
stabilization of PI in the P-1C treatment at weeks 3 and 5 suggests that PI may be vitally
important in controlling initial infections. Although it appears naive oysters can respond
positively to P. marinus challenges in the short term, it appears that oysters are unable to
maintain PI beyond baseline PI activity and that eventually P. marinus is able to
overcome host expression o f inhibitor. The mechanism of overcoming host inhibitor is
not known. It is possible that there may be a competitive over-expression of protease
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versus inhibitor or there may be a direct suppressive effect on inhibitor expression. The
continual decrease in non- specific PI activity in the ASW treatment from week 3 to 5
p.c. cannot be explained. However, non-specific PI activity in the ASW treatment
initially appears to follow a similar pattern to the P-1C treatment as PI activity dropped
from week 1 to 3 to near the baseline level. This is in contrast to the P-l treatment where
non-specific PI activity dropped below baseline the level at week 3 p.c. Although it is
tempting to conclude that live P. marinus secretory products continually scavenged host
inhibitor over time in the P-l treatment, the precipitous drop in PI at week 5 p.c. in the
ASW treatment precludes this conclusion.
The induction o f humoral factors in molluscs exposed to non-self antigens or
pathogens is not unprecedented. Anderson (1981) observed the induction of hemolytic
activity in the clam, Mercenaria mercenaria, toward mammalian erythrocytes and posed
its protective function in the host. Olafsen et al. (1992) observed the induction of
agglutinin activity in Pacific oysters (Crassostrea gigas) after challenging with Vibrio
anguillarum and suggested that agglutinins are involved in enhancing bacterial clearance.
Montes et al. (1996) observed the induction of a 225 kDa protein believed to be important
in defense against Perkinsus spp. Additional studies have attempted to associate humoral
factors with disease resistance in oysters; however, there has yet to be conclusive
evidence that certain humoral factors confer resistance. Ford (1986) compared
hemolymph proteins from resistant and susceptible oysters exposed to MSX, but found
that SDS-PAGE banding patterns could not be correlated with resistance. Chintala et al.
(1991) observed significantly higher agglutination titers for Vibrio cholerae in MSXresistant oysters, however, Chintala et al. (1994) found no correlation between parasite
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densities and agglutination titers and concluded that serum agglutinins played no role in
defense against H. nelsoni or P. marinus.
All oysters were diagnosed for P. marinus infections after the final bleed. The P-l
treatment had an average P. marinus infection of 0.63 on the Mackin scale. Thus, it
appears that only light infections with P. marinus are required to reduce non-specific PI
activity. It is unclear how PI activity would behave beyond light infections. Continual
reduction in PI activity to undetectable levels might occur, however, extended monitoring
of PI activity over time is needed to confirm this. No significant difference in non
specific PI activity was detected between uninfected and lightly infected oysters. This
seems to contradict the observation that non-specific PI activity was dramatically lower
in the P-l treatment at weeks 3 and 5. The lower sample size in the lightly infected group
(N = 7) versus the uninfected group (N = 31) may account for the absence of a statistical
difference.
It is interesting to note that the increase in non-specific PI activity in the P-l
treatment at week 1 was approximately 25% while the increase in the P-1C treatment was
over 100%. One reason that may account for the differential increase in PI activity at
week 1 is that in the P-l treatment the pathogen is continually expressing protease. This
would lead to a removal of unbound or free host inhibitor resulting in less of an increase
in PI compared to the P-1C treatment. The observation that non-specific PI activity was
induced in oysters injected with artificial seawater (ASW) would lead to the conclusion
that the PI response is not antigen-specific. To determine whether the PI induction is
antigen-specific to protease, P. marinus membranes would need to be stripped o f protease
and an additional control group receiving no injection would need to be included.
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The variations in PI during this experiment is reflective of only a short, albeit
concentrated, dose of in vitro cultured P. marinus cells over the course of one week. It
should be noted that oysters in the wild are not likely to be exposed to such a density of
cells in such a short time span and thus, the PI may not vary as widely due to P. marinus
infections as observed herein. This does not preclude the observation that PI may exhibit
changes of the same magnitude in the wild. One reason for this would be the presence of
other pathogens capable o f altering PI. The dosage used in this experiment was
determined according to previous reports detailing the numbers of cells required to
establish an infection (Chu, 1996; Chu, 1997; Bushek et al., 1997). Furthermore, the
establishment of only light infections after five weeks p.c. is consistent with the findings
of these investigators.
This study has demonstrated the variability in PI in naive, susceptible oysters and
how PI changes after challenges with live and killed P. marinus. Although the data is not
conclusive, it suggests that P. marinus secretory products can exert deleterious effects on
the host’s ability to maintain PI throughout an infection. The long-term role o f PI in
oyster humoral defense against P. marinus is unclear. In the short term, it appears that PI
is incapable of eliminating P. marinus infections. Perhaps a longer infection study
employing an additional group of naive Dermo-resistant oysters might further elucidate
the role of PI in controlling P. marinus infections.
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Figure Legends
Figure la. Mean plasma protein concentration (mg/ml) during challenge experiment.
Error bars represent the standard error. Time (in weeks) post-challenge is denoted by the
numbers above the bars and is the same for each treatment. Treatments defined as
follows: P-l, live P. marinus-l challenge; P-1C, formalin treated/heat killed P. marinus-l
challenge; ASW, artificial seawater challenge (22 mg/1).

Figure lb. Mean specific protease inhibitory (PI) activity. Asterisks denote significant
differences from the prebleed (p<0.001). Error bars represent the standard error. Time (in
weeks) post-challenge is denoted by the numbers above the bars and is the same for each
treatment.

Figure lc. Mean non-specific protease inhibitory (PI). Asterisks denote significant
differences from the prebleed (p<0.001). Error bars represent the standard error. Time (in
weeks) post-challenge is denoted by the numbers above the bars and is the same for each
treatment.

Figure 2a. Mean change in specific PI activity from baseline. Baseline PI activity was
measured 3 weeks prior to challenge. Each bar represents the mean change in PI activity
at weeks 1, 3, and 5 post-challenge.

Figure 2b. Mean change in non-specific PI activity from baseline. Baseline PI activity
was measured 3 weeks prior to challenge. Each bar represents the mean change in PI
activity at weeks 1,3, and 5 post-challenge.
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General Discussion
This thesis explored the associations of protease inhibitors of the eastern oyster,
Crassostrea virginica, with infections by the oyster pathogen, Perkinsus marinus.
Specifically, protease inhibitory (PI) activity was detected in the plasma of oysters. This
PI activity was determined to be o f low molecular weight (<10 kDa) and demonstrated
specificity for P. marinus extracelluar proteases. Additionally, PI activity was capable of
preventing the digestion o f a sensitive plasma protein target (35 kDa) in the oyster by P.
marinus extracellular proteases. From these findings, a protective function of PI activity
was postulated with respect to Dermo disease resistance.
Selectively bred families o f oysters with high genetic variability and exhibiting wide
ranges of resistance to Dermo were analyzed for PI activity in an attempt to discern a
relationship between PI activity and susceptibility. A positive correlation was found
between family survival and mean family PI activity. A significant negative correlation
between Dermo intensity (Mackin scale) and PI activity was also observed. Three
selected stocks of oysters, one MSX/Dermo-resistant and two Dermo-susceptible stocks,
were also analyzed for PI activity and susceptibility to Dermo. No significant
relationship between stock survival and PI activity was discerned. However, there was a
significant negative correlation between Dermo intensity and PI activity as seen in the
selectively bred families. PI activity dynamics was explored in a P. marinus challenge
experiment. Results indicate that PI activity is inducible in oysters challenged with live

128

and dead P. marinus. It is unclear whether this induction is antigen-specific or a non
specific response to challenge.
The positive correlation between PI activity and survival in the selectively bred
families of oysters lends support to the hypothesis that PI activity plays a protective role
in resisting P. marinus infections. An additional piece of evidence that supports PI
activity as important in humoral defense against P. marinus is the finding that PI activity
negatively correlated with Dermo intensity. The results of the in vivo P. marinus
challenge, however, were inconclusive with respect to supporting these earlier findings.
It is likely that a similar challenge experiment performed over a longer time scale might
lend support to the protective role of PI activity. The variability in PI activity within
selectively bred families and groups of oysters make it difficult to discern to what degree
PI activity alone is capable of protecting oysters from P. marinus infections. Some
families exhibited high PI activity and low mortality, but also there were families/groups
that exhibited low PI activity and low mortality. Only when all oysters are considered,
irrespective of family or group, are differences in PI activity with respect to disease
intensity revealed. These results, albeit encouraging, are by no means comprehensive in
elucidating the mechanism(s) o f disease resistance to P. marinus. The findings herein do
not support PI activity as being a substantial mechanism in resistance to P. marinus. This
is clear when one considers that all putatively resistant oysters challenged in the field
with P. marinus still contracted the disease, albeit in low intensities at times. Thus, if PI
activity does have a role in humoral defense, it may be through conferring tolerance
rather than complete resistance to P. marinus. It is possible that PI activity plays only a
minor role in humoral defense against P. marinus and the temporal nature of such a
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defense factor during the disease process is unfortunately subject to speculation at this
time. It is clear that further studies are warranted in order to corroborate the findings
herein.
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